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A mammalian cell with defined developmental potency can be converted to a 
pluripotent stem cell that has the potential to differentiate into any of the three germ 
layers: endoderm, mesoderm, or ectoderm. This reprogramming phenomenon offers a 
number of potential clinical applications, especially for diseases with a genetic 
basis. Several strategies have been applied to achieve cell reprogramming, including 
somatic cell nuclear transfer (SCNT), cell fusion, inducing pluripotent stem (iPS) with 
overexpression of several key pluripotency-associated transcription factors. However, 
these current approaches are limited in cell source, reprogramming efficiency, or 
application safety, which rescrict their potential applications in research and clinical 
treatment. Besides, the underlying reprogramming mechanisms remain largely 
unknown. And it is unclear whether intrinsic genetic and epigenetic characteristics of a 
lineage-restricted cell can affect reprogramming process. 
This thesis is focused on the impact of the epigenome on mammalian cell fate 
conversion from unipotency to multi-/pluri-potency. In Chapter one, we studied the 
spontaneous conversion from cultured mouse spermatogonial stem and progenitor 
cells (SSCs) to multipotent adult spermatogonial-derived stem cells (MASCs). In 
Chapter two, we performed time-series study on transcription factor-induced mouse 
embryonic fibroblasts (MEFs) reprogramming. In each model system, we applied high 
throughput sequencing and bioinformatics analyses to dissect both transcriptome and 
epigenome defined by transcription-associated histone modifications and histone 
variant exchange.  
We found in SSCs that many genes essential to pluripotent stem cell maintenance 
and differentiation were enriched with both histone H3 lysine 4 and lysine 27 
trimethylation modifications (K4me3+K27me3) at promoter regions. After SSC 
conversion, promoter histone modifications were restrictively changed at 
pluripotency- or germline-specific genes but remained repressive for most somatic 
genes, bestowing MASCs with pluripotency-associated promoter chromatin states. At 
enhancer regions, the core pluripotency circuitry was activated partially in SSCs and 
completely in MASCs, concomitant with global erasure of germ cell-specific enhancer 
activity and initiation of an embryonic-like program. In addition, histone variant H3.3, 
which is specifically enriched at core pluripotency genes in SSCs, was potentially 
involved in chromatin remodeling and pluripotency gene reactivation during the 
reprogramming of differentiated MEFs. 
These results suggest that unipotent SSCs encode their innate developmental 
flexibility by means of the epigenome and that both the promoter chromatin state, and 
the activity of cell-type-specific enhancers are prominent features of SSC 
reprogramming. Besides, our finding of the gene-specific epigenetic conversion during 
mammalian cell reprogramming provides insights into the development of new 
strategies to achieve pluripotency. 
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INTRODUCTION 
 
I. Spermatogonial Stem and Progenitor Cells (SSCs) 
1. SSCs specification, development, and differentiation 
a. Embryonic origin of SSCs 
Mammalian spermatogonial stem and progenitor cells (SSCs) are the only germline 
stem cells that differentiate to all subsequent germ cells in the adult male gonad. In 
mice, primordial germ cells (PGCs), the embryonic precursors of SSCs, originate from 
the post-implantation epiblast cells between embryonic day (E) 6.0 and 6.5, and 
establish a cluster of about 45 cells at E7.25 (Figure 1) (Ginsburg et al., 1990). Upon 
germline specification, somatic genes are mainly repressed in PGCs (Saitou et al., 
2002), while expression of several embryonic stem cells (ESCs) signature 
transcription factors (e.g., Pou5f1/Oct4, Nanog, Sox2, Lin28a, etc.) are reactivated 
(Pesce et al., 1998; Yamaguchi et al., 2005; Yabuta et al., 2006; Kurimoto et al., 2008; 
West et al., 2009). PGCs are therefore distinct from somatic cells with repression of 
somatic transcriptome  and expression of ESCs signature genes, which retrieve 
pluripotent developmental potency in this cell population. Subsequently, PGCs 
migrate into the male genital ridge between E10.5 and E11.5, proliferate in the 
embryonic gonad till E13.5, and enter G1-phase mitotic arrest as gonocytes 
(prospermatogonia) after E13.5 (Figure 1). Many PGC-specific genes are activated in 
the genital ridge, including Ddx4, Sycp3, Dazl, etc. (Sasaki and Matsui, 2008). 
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Figure 1. PGC specification and migration in post-implantation embryo. 
(Adapted from 2001 Terese Winslow, Caitlin Duckwall) 
 
b. Spermatogonial self-renewal 
Within the first week after birth, some mouse gonocytes resume proliferation and 
mature into single spermatogonia (As), which are morphologically distinct from their 
cell division progenies in that they do not have heterochromatin and intercellular 
bridges (Figure 2A) (de Rooij and Russell, 2000). These As spermatogonia locate in 
the basal lamina of the seminiferous tubules, form the first wave of spermatogenesis 
and establish the initial pool of SSCs (Figure 2B) (Oatley and Brinster, 2006). In adult 
mouse testes, As spermatogoina was estimated to represent about 0.03% of germ cells 
by whole mounts of seminiferous tubules (Tagelenbosch and De Rooij, 1993). 
However, only about 10% of As spermatogoina functioned as SSCs in transplantation, 
presumably dues to the low efficiency of passage through the blood-testis barrier 
(BTB) to the stem cell niche (Nagano et al., 1999). Indeed, SSC homing was shown to 
be more efficient in immature pup testis that lacks BTB tight junctions between Sertoli 
cells (Shinohara et al., 2001). 
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Figure 2. Germ cell development in mice.  
(A) Spermatogenesis in postnatal mouse testes. (Adapted from (Yoshida, 2008))  
(B) Schematic illustration of mammalian spermatogenesis. (Adapted from (Rato et al., 
2012)) 
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SSCs undergo self-renewal in the niche determined by Sertoli cells (Figure 2B) 
(Oatley et al., 2011b). As the only somatic cells that directly interact with germ cells, 
Sertoli cells not only provide structural support but also growth factors essential for 
the maintenance of SSC self-renewal. The key Sertoli cell-secreted growth factors 
include glial cell line-derived neurotrophic factor (GDNF) (Meng et al., 2000) and 
fibroblast growth factor 2 (FGF2) (Ishii et al., 2012), both can support SSC self-
renewal and proliferation in vivo and in vitro. 
Besides growth factors,  several transcription factors are involved in SSC self-
renewal (Phillips et al., 2010; Kanatsu-Shinohara and Shinohara, 2013). Studies with 
knock-out mouse models suggested that Zbtb16/Plzf (Buaas et al., 2004; Costoya et al., 
2004), Etv5 (Chen et al., 2005; Morrow et al., 2007), Taf4b (Falender et al., 2005), Id4 
(Oatley et al., 2011a), and Bcl6b (Oatley et al., 2006) function in a cell-autonomous 
manner to maintain SSC self-renewal, and the mutant mice progressively lose 
spermatogenesis in part or whole testes. Notably, the expression of several ESC 
signature transcription factors (i.e., Pou5f1/Oct4 (Pesce et al., 1998), Sox2 (Arnold et 
al., 2011), Lin28a (Zheng et al., 2009), etc.) are also confined to the undifferentiated 
spermatogonia, although their roles in SSC development are not well characterized 
(Seandel et al., 2010). Conversely, SSCs do not express genes that promote embryonic 
somatic cell development, which is similar to their progenitor PGCs in post-
implantation embryo. 
The As spermatogonia (including SSCs) also express several stem cell-specific cell 
surface antigens. For example, mouse testicular cells with α6- and β1-integrin preserve 
stem cell activity (Shinohara et al., 1999), and SSCs were found nearly exclusively in 
the Thy-1+c-kit- cells (Kubota et al., 2003). Besides, Gfrα1 (Meng et al., 2000) and 
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GPR125 (Seandel et al., 2007) were also reported as potential SSCs marks in 
mammals. 
 
c. Postnatal development and differentiation of SSCs 
As unipotent stem cells, SSCs undergo both self-renewal and differentiation 
throughout adulthood. The fate decision of a SSC to produce differentiating progeny 
initiates spermatogenesis in postnatal mouse testes (Figure 2A) (Oatley and Brinster, 
2006). During this process, As spermatogonia (including SSCs) take a series of mitotic 
cell divisions to generate both undifferentiated spermatogonia (Aundiff) and 
differentiating spermatogonia (Adiff), which then undergo meiotic cell divisions to 
generate spermatocytes and haploid spermatozoon (Figure 2A) (Yoshida, 2008). The 
Adiff spermatogonia are distinguishable from Aundiff spermatogonia on the basis of 
many characteristics including being c-kit positive (Shinohara et al., 1999; Ohta et al., 
2003). Correspondingly, study with mutant mouse has clearly demonstrated that c-kit 
expression is a distinctive and critical step of the spermatogonia differentiation 
(Yoshinaga et al., 1991). However, no known SSC-specific cell surface antigen has 
been found to distinguish SSCs from other types of Aundiff spermatogonia.  
From sexual maturity onward, Adiff spermatogonia undergo mitotic division to 
form primary spermatocytes (spermatocytes I), which then activate meiotic 
differentiation and divide two times into diploid secondary spermatocytes 
(spermatocytes II) and then haploid round spermatids. During post-meiotic 
spermatogenesis, nucleosomal histones in round spermatids are firstly replaced by 
basic transition nuclear proteins (TNPs) and then by protamines. This histone-to-
protamine exchange packages the genome in extremely compact formation and yields 
mature spermatozoa, which are the transcriptionally inert final product of 
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spermatogenesis. Theoretically, 4096 spermatozoa can be produced from a mouse As 
spermatogonium after 12 cell divisions. And one spermatogenesis cycle takes 35 days 
to complete in mice (Russell et al., 1990). 
The continuous cell differentiation process generates highly heterogeneous 
germinal population in adult testes. Because the meiosis process induces extensive 
variations in DNA content and chromatin structure, germ cells at multiple stages of 
spermatogenesis can be analyzed and isolated by flow cytometry using Hoechst 33342 
(Ho) dye, which diffuses through cell plasma membrane and binds with high affinity 
to poly(d[AT]) sequences in the DNA minor groove. Ho staining methodology can 
efficiently discriminate preleptotene spermatocytes (meiosis prophase I), spermatocyte 
I (diploid), spermatocyte II (haploid), round and elongated spermatids (haploid). 
Basing on the efflux of Ho, a side population (SP) that was suggested to contain SSCs 
can also be isolated by flow cytometry (Figure 3) (Bastos et al., 2005). 
 
 
 
 
 
 
 
 
Figure 3. Flow cytometric analysis of Hoechst 33342 stained adult mouse 
testicular cells. 1, preleptotene spermatocytes (at last S phase before meiosis. DNA 
content: between 2c and 4c). 2, spermatocyte I (at meiosis prophase I. DNA content: 
4c). 3, spermatocyte II (at post-meiosis I. DNA content: 2c). 4, spermatid (at post-
meiotic. Hapolid DNA content: 1c). SP, side population with premeiotic 
spermatogonial including SSCs. (Adapted from Figure 1A (Bastos et al., 2005)) 
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2. Characteristics of SSC culture 
a. Isolation and long-term expansion of SSCs 
The long-term expansion of mouse SSC culture provides a key tool for studying SSC 
biology at the cell and molecular level in vitro. To establish a culture, an SSC-
enriched cell population can be collected from whole testicular cells by several 
methods, including use of spermatogenesis-defective experimental cryptorchid donors 
(Shinohara et al., 2000a), isolation by cell surface antigens (Shinohara et al., 1999; 
Kubota et al., 2003; 2004a; 2004b), and differential plating (Shinohara et al., 2000b). 
SSCs typically show grapelike morphology on feeder cells and can be passed for years 
without losing fertility (Figure 4A) (Kanatsu-Shinohara et al., 2003). Besides, Aundiff 
spermatogonia specific cell surface antigens α6-integrin and Thy-1 are stably 
expressed in 80 – 90% of long-term expanded cells (Figure 4B). Notably, as it has 
been reported that all types of Aundiff spermatogonia share similar cell surface antigens, 
SSCs have not been able to be specifically isolated from Aundiff spermatogonia. As a 
result, SSC culture is a heterogeneous population with SSCs and other types of Aundiff 
spermatogonia (Kanatsu-Shinohara and Shinohara, 2013). It was reported that the 
fluorescence-activated cell sorting (FACS) isolated Thy-1+c-kit- cells contains nearly 
all the SSCs with about 6% purity (1 in 15 cells is an SSC) (Kubota et al., 2003). And 
only about 1–2% of long-term cultured SSCs were estimated to exhibit testicular 
repopulation capacity (Kanatsu-Shinohara et al., 2005b). However, many groups also 
reported that even c-kit+ differentiating germ cells that presumably lose stem cell 
activity can convert back to SSCs in vivo (Barroca et al., 2009) and in vitro 
(Nakagawa et al., 2007). Thus, SSC frequency in culture could be much higher than 
previously estimated (Kanatsu-Shinohara and Shinohara, 2013). 
To support stem cell self-renewal and survival without promoting the growth of 
 8 
contaminating somatic cells, SSCs need to be expanded in a serum-free or serum-low 
(1%) condition (Kubota et al., 2004a; Kanatsu-Shinohara et al., 2005a). Moreover, 
many growth factors have been examed for their ability to promote SSC expansion in 
vitro, including GDNF, FGF2, epidermal growth factor (EGF), leukemia inhibitory 
factor (LIF), and stem cell factor (SCF, kit ligand) (Kubota et al., 2004a). Among 
them, GDNF plays a critical role to maintain and stimulate SSC self-renewal in long-
term culture (Kubota et al., 2004b). The central importance of GDNF on SSCs 
expansion in vitro well reflects its function in mouse spermatogonia development in 
vivo (Meng et al., 2000), and has been validated in many other mammalian species 
(Hamra et al., 2005; Sadri-Ardekani et al., 2009). Based on these findings, Kanatsu-
Shinohara et al. developed a long-term SSC culture system with GDNF, FGF2, EGF, 
and LIF. With or without mouse embryonic fibroblasts (MEFs) as feeder cells, SSCs 
derived from both neonatal and adult mouse testes can stably proliferate in this 
medium for more than two years and retain spermatogenesis capability (Kanatsu-
Shinohara et al., 2003; 2004; 2005a). Although LIF is suggested to promote the 
survival of gonocytes in newborn testicular cell culture, it is dispensable for SSC self-
renewal. And SSC culture can be established from pup or adult testes without LIF 
(Kanatsu-Shinohara et al., 2007). Study in Dr. Rafii’s lab also established a novel 
CD34+ testicular stromal cell line (JK1) that facilitates long-term SSC culture. And 
SSCs maintained on either MEFs or JK1 share similar biology characteristics (Kim et 
al., 2008). Therefore, I derived and expanded adult mouse SSCs in the medium 
designed by Kanatsu-Shinohara et al. without LIF, and used JK1 or MEFs as feeder 
cells.  
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Figure 4. Long-term SSC culture preserves spermatogonia specific 
characteristics.    
(A) Mouse SSC culture on MEFs.  
(B) Flow analysis of spermatogonia specific cell surface antigens.  
 
b. Evaluation of stem cell characteristics in SSC culture 
To evaluate spermatogenesis and germline transmission capabilities of in vitro 
expanded SSCs, a spermatogonial transplantation technique was developed. The 
technique involves microinjection of dissociated donor testicular cells into the 
seminiferous tubules of germ cell-depleted or -deficient recipient testes. After 
injection, SSCs within the donor cells migrate and colonize stem cell niches on the 
basement membrane, repopulate, reinitiate spermatogenesis, and produce offspring 
with the donor haplotype (Figure 5). This donor-derived spermatogenesis produces 
mature spermatozoon after 35 days, corresponding to one spermatogenesis cycle in 
vivo. This result further confirms that the donor SSCs but not differentiating 
 10 
spermatogonia contribute to the spermatogenesis (Brinster and Avarbock, 1994; 
Brinster and Zimmermann, 1994). At present, spermatogonial transplantation is the 
only functional SSC assay that not only directly validates the presence of SSCs but 
also investigates their biological characteristics as unipotent germline stem cells in 
vivo (Oatley and Brinster, 2006). Besides, the transplantation assay confirmed that 
SSCs increased their number during in vitro proliferation.  
The cultured SSCs expressed both embryonic and spermatogonial specific genes 
as Aundiff spermatogonia in vivo. SSCs in long-term culture express many ESC-
signature transcription factors, including Pou5f1/Oct4 (Kanatsu-Shinohara et al., 
2005b; Seandel et al., 2007; Dann et al., 2008), Klf4 (Kanatsu-Shinohara et al., 2008), 
Lin28a (my data). However, the expression level of these pluripotency-associated 
genes is lower than ESCs by either mRNA or protein, and no mRNA or functional 
proteins were identified for Sox2 (Imamura et al., 2006; Seandel et al., 2007) and 
Nanog (Kanatsu-Shinohara et al., 2004; Seandel et al., 2007) in cultured SSCs. SSCs 
also express many well-characterized spermatogonia marks, including Zbtb16/Plzf, 
Etv5, Id4, Bcl6b, GPR125, Gfrα1, Pou3f1/Oct6 (Wu et al., 2010), Piwil4 (Carmell et 
al., 2007), etc. (Seandel et al., 2007). However, genes that regulate embryonic 
differentiation to somatic lineages are mostly silenced in cultured SSCs, for example, 
Hox family, Prmt8, etc. (see Chapter I). 
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Figure 5. The SSC transplantation technique in mice.  
The donor cells with a germ cell-expressed reporter transgene are collected from long-
term culture or male testes (A) and digested to become a single-cell suspension (B). 
These cells are subsequently microinjected into the seminiferous tubules of an infertile 
germ cell-depleted recipient (C). Donor SSCs can colonize and undergo 
spermatogenesis in recipient testes. After 3 – 5 months, colonies that express the donor 
cell-carried reporter transgene can be detected in the recipient testes (D). Each donor-
derived colony is generated from a single transplanted SSC. After mating the recipient 
male to a wildtype female (E), offsprings with the donor haplotype can be produced 
(F). (Adapted from Figure 1 (Oatley and Brinster, 2006)) 
 
3. SSC reprogramming to multipotency 
a. Potential pluripotency of SSCs 
As the precursors of germ cells, mammalian SSCs undergo unipotent differentiation in 
adult male gonad, while still possess ultimate totipotent developmental potency to 
propagate across generations. One example of the unique association between germ 
cells and pluripotency is the spontaneous formation of teratomas in strain 129 mice 
(Stevens and Little, 1954). Teratomas contain tissues derived from all three germ 
layers, suggesting that germ cells in both postnatal and adult testes retain 
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developmental potency unrestricted to germline. Besides, direct trans-differentiation 
of spermatogonia into somatic lineages has also been observed upon changing the cell 
microenvironment (Boulanger et al., 2007) or using a tissue recombination 
methodology (Simon et al., 2009).  
The expression of key pluripotency regulators and repression of somatic genes in 
both Aundiff spermatogonia in vivo and SSC culture in vitro clearly show that unipotent 
SSCs and pluripotent ESCs share many similarities in transcriptomes. Pou5f1/Oct4, 
together with Sox2 and Nanog, form the core pluripotency circuitry in ESCs to 
maintain stem cell self-renewal and to control the expression of many differentiation 
genes (Boyer et al., 2005; Loh et al., 2006). It is not known whether the modest level 
of Pou5f1/Oct4 expression exerts similar or partial function in pluripotency regulation 
in SSCs. 
 
b. Multipotent adult spermatogonial-derived stem cells (MASCs) 
Several groups reported that multipotent adult spermatogonial-derived stem cells 
(MASCs) can be derived during in vitro expansion of mouse unipotent SSCs (Figure 
6). MASCs share many common features with pluripotent ESCs, including capabilities 
to differentiate into various somatic cells in vitro, to induce teratomas in vivo, and to 
form germline chimera after blastocyst injection (Figure 6) (Kanatsu-Shinohara et al., 
2004; Guan et al., 2006; Seandel et al., 2007; Izadyar et al., 2008; Kossack et al., 
2009). MASCs do not contribute to spermatogenesis after being transplantated to 
seminiferous tubules, suggesting that they lose the capability to differentiate to germ 
cells (Kanatsu-Shinohara et al., 2008). Notably, SSCs isolated from both neonatal and 
adult testes are capable of this spontaneous conversion to multipotency (Kanatsu-
Shinohara et al., 2004; Seandel et al., 2007). To date, this is the only known 
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reprogramming event that converts unipotent adult stem cells back to a near 
pluripotent state without delivery of exogenous genes or gene products, which 
distinguishes it from induced pluripotent stem (iPS) cell formation (Takahashi and 
Yamanaka, 2006). However, the spontaneous and sporadic SSC conversion process 
takes more than 4 weeks to generate multipotent MASCs, and the reprogramming 
efficiency can be 100-fold lower than generating iPS from MEFs (Kanatsu-Shinohara 
et al., 2004; Seandel et al., 2007). Many methods were suggested to improve SSC 
conversion, including deriving SSCs from neonatal or p53 KO mice (Kanatsu-
Shinohara et al., 2004), isolating an unique germ cell population by SSC-specific 
marks (Seandel et al., 2007; Izadyar et al., 2008), initiating culture with low cell 
density (Ko et al., 2009), or applying LIF and glycogen synthase kinase-3 (GSK-3) 
inhibitor CHIR99021 in culture (Moraveji et al., 2012). 
MASCs share similar characteristics with ESCs in their differentiation potency 
both in vitro and in vivo. Many studies showed that MASCs can be differentiated to 
functional neurons (Glaser et al., 2008), mature hepaticphenotype (Loya et al.), 
cardiomyocytes (Baba et al., 2007), and endothelial cells (Seandel et al., 2007), etc. 
Interestingly, MASCs were reported to express higher levels of mesodermal marks 
than ESCs (Seandel et al., 2007). In vitro differentiation assay also showed that 
MASCs are more efficient in generating mesodermal cells comparing to ESCs, 
suggesting that un-equivalent differentiation preferance toward mesodermal lineage 
could be a specific characteristic in MASCs (Baba et al., 2007). 
These observations indicate that intrinsic genetic and epigenetic features rather 
than enforced expression of ectopic transcription factor(s) are responsible for 
reprogramming of SSCs. However, the underlying mechanisms of SSC conversion 
remain largely unknown.  
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Figure 6. SSCs convert to MASCs. 
Unipotent SSCs (red) derived from adult mouse testes and expanded in vitro are 
capable of spontaneous reprogramming to multipotent MASCs (light green), which 
share similar stem cell characteristics with pluripotent ESCs (dark green) that are 
derived from inner cell mass (ICM) in the preimplantation embryo. Images of in vitro 
cultured SSCs and MASCs are adapted from (Seandel et al., 2007). 
 
 
 
 
 
 
SSCs 
 
(Unipotent) 
MASCs 
 
(Multipotent) 
ESCs 
 
(Pluripotent) 
Spontaneous Reprogramming  
Testis 
Sperm    Oocyte ICM 
PGCs 
GPR125 GPR125 
Seandel M, Rafii S, et al. Nature 2007 
Figure 4 
 15 
II. Epigenetic Regulation of Transcription 
1. Histone modification 
In eukaryotic cells, DNA is tightly packed with proteins to form chromatin, which has 
nucleosome as its basic subunit. Nucleosome is composed of an octamer of core 
histone proteins (two copies of H2A, H2B, H3 and H4) wrapped with ∼146 base pairs 
of DNA (Figure 7A). As one of the most stable protein-DNA complexes under 
physiological conditions, nucleosome organization directly influences almost all 
DNA-related processes including replication, repair and transcription. This unique 
character makes nucleosome an important regulator in eukaryotic cell development 
(Kouzarides, 2007). 
Nucleosomes are not static, they are instead dynamically regulated by many 
binding proteins. Among them, histones contribute most of the diversity through their 
post-translational modifications (PTMs) and variants (Hake and Allis, 2006; 
Ruthenburg et al., 2007). Because histone PTMs and variants may change the 
chromatin character and regulate gene expression without changing the underlying 
DNA sequence, they are proposed to be “epigenetic” factors that regulate eukaryotic 
cell diversity. And “epigenetics” is defined as “the study of any potentially stable and, 
ideally, heritable change in gene expression or cellular phenotype that occurs without 
changes in Watson-Crick base-pairing of DNA” (Goldberg et al., 2007). 
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Figure 7. Nucleosome, histone, and histone PTMs. 
(A) Nucleosome core particle. Left, a view down the DNA superhelix axis. Right, a 
view perpendicular to the DNA superhelix axis. Brown and turquoise, 146-bp 
DNA phosphodiester backbones. Blue, H3. Green, H4. Yellow, H2A. Red, H2B. 
(Adapted from Figure 1a (Luger et al., 1997)) 
(B) Histone PTMs in the N-terminal tail of canonical H3. Blue flag, acetylation. Red 
hexagon, methylation. Yellow circle, phosphorylation. Number under each amino 
acid, position in the sequence. 
(C) Sequential methylation on lysine. 
Figure 5 
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a. Histone post-translational modifications (PTMs) 
The four core histones (H2A, H2B, H3 and H4) are relatively similar in structure and 
size, and their sequences are highly conserved from yeast to human. Their C-terminal 
regions form stable globular structures and are deeply buried within the nucleosome. 
But the unstructured N-terminals protrude from the nucleosome particles and form 
flexible “tails” (Figure 7A).  
Histones regulate nucleosome plasticity mainly through the PTMs on their amino 
acid residues. Many types of modifications have been identified, including 
methylation, acetylation, phosphorylation, ubiquitination, sumoylation, etc. Most of 
the PTMs locate on the residues within the N-terminal “tails” (Figure 7B)(Ruthenburg 
et al., 2007). Many PTMs have been found to be dynamic, and enzymes that 
specifically modify different residues have been well identified. Proteins and domains 
that preferentially associate with different PTMs have also been intensively studied. 
Histone PTMs provide the chromatin diversity by regulating the contacts between 
nucleosomes, as well as by recruiting various protein cofactors to chromatin. Both can 
affect cell development through many DNA-related processes, including transcription 
(Kouzarides, 2007). 
 
b. Lysine methylations & enzymes 
Among all the known PTMs, lysine methylation is one of the best studied 
modifications. In eukaryotes, lysine (K) can be sequentially methylated to three forms: 
monomethylation (Kme), dimethylation (Kme2), or trimethylation (Kme3) (Figure 
7C). Different lysine residues can be modified in each histone tail, each form of 
modification (mono-, di-, or tri-methyl) on a specific lysine residue may couple with a 
special cellular event and process a unique function (Shilatifard, 2008). 
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Many site-specific lysine methyltransferases (HMTs) and demethylases (KDMs) 
have been identified. For example, H3 lysine 4 residue (H3K4) can be specifically 
trimethylated by MLL/WRD5 complex (Wysocka et al., 2005) and demethylated by 
JARID1/KDM5 family proteins (Christensen et al., 2007; Iwase et al., 2007; Yamane 
et al., 2007). H3 lysine 36 residue (H3K36) can be methylated by NSD1 and 
demethylated by Jhdm1b (Rayasam et al., 2003; He et al., 2008). The polycomb 
repressive complex 2 (PRC2) is responsible for the (di- and tri-) methylaiton of H3 
lysine 27 residue (H3K27) through its enzymatic subunits Ezh1 (Shen et al., 2008) and 
Ezh2 (Margueron et al., 2008; Margueron and Reinberg, 2011), whereas UTX and 
JMJD3 can erase the methylation from K27 (Agger et al., 2007; Lan et al., 2007). 
 
c. Histone PTMs & transcriptional regulation 
Methylation on the residues H3K4 and H3K36 are implicated in activation of 
transcription. In yeast, H3K4 trimethylation (K4me3) is established together with 
transcription elongation and requires association with RNA Polymerase II (RNAP II) 
(Li et al., 2007). But these modifications do not affect transcription elongation or 
processivity of RNAP II (Mason and Struhl, 2005). However, H3K36 trimethylation 
(K36me3), a modification established by Set2 following elongation, can specifically 
recruit Eaf3 and mediate deacetylation of newly deposited histones. This process is 
proposed to erase the transcription elongation-coupled histone acetylation and avoid 
intragenic transcription initiation (Carrozza et al., 2005). Our knowledge in yeast 
PTMs leads us to propose their similar functions in higher eukaryotes. However, 
mammalian core histones are normally encoded in multi-copied tandem clusters, 
which add great challenge to genetic manipulation (Sierra et al., 1982). As a result, the 
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precise function of many PTMs in mammalian cell differentiation and organ 
development still remains myserious. 
Besides of active marks described above, trimethylation on H3K9 (K9me3) and 
H3K27 (K27me3) are associated with transcriptional repression. Methylation at H3K9 
is implicated in the heterochromatin formation and silencing of enchromatic genes 
with the recruitment of HP1 to the promoters. K27me3 modification has been 
implicated in the silencing of HOX gene and imprinting genes (Kouzarides, 2007).  
Recently, genome-wide studies in different eukaryotic organisms showed that 
methylations on many lysine residues are tightly regulated and significantly associated 
with transcription (Figure 8). For example, K4me3 is specifically enriched around 
transcription start site (TSS) of active genes, while K36me2/3 and trimethylation on 
H3 lysine 79 residue (K79me3) only exist within the body of transcribing genes. 
These localization patterns are well conserved from yeast to human (Bernstein et al., 
2005; Pokholok et al., 2005). Furthermore, these modification levels are positively 
correlated to the transcription frequency (Pokholok et al., 2005). Besides, H3K4 
mono-/di-methylation (K4me1/2) and H3K27 acetylation (K27ac) enrichments at cis-
regulatory DNA elements associate with the activation of these enhancers, which 
recruit transcription factors, RNAPII and chromatin regulators to positively influence 
transcription at distal promoters (Zhou et al., 2011). Conversely, the repressive marks 
K9me2/3 and K27me3 are often found in large broad domains in differentiated 
mammalian tissues, but K27me3 is more focal at developmental gene promoters in 
pluripotent ESCs (Wen et al., 2009; Hawkins et al., 2010). It will be interesting to 
know whether these PTMs are merely markers passively added during transcription, or 
they can play positive roles in regulating mammalian gene transcription. 
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Indeed, accumulating evidences reveal the key regulatory functions of histone 
PTMs in gene expression. Because K4me3 is a mark for active transcription, it is 
proposed to provide signal for transcription initiation and transcription frequency 
(Wysocka et al., 2005; Li et al., 2007). This hypothesis is supported by the 
identification of many K4me2/3 specific binding proteins, which all contain plant 
homeodomain (PHD) finger and are proposed to interpret K4me3 mark to multiple 
transcriptional events (Zhang, 2006). These PHD finger proteins are associated with 
many transcription cofactor complexes, including chromatin-remodeling factor NURF 
(BPTF) and histone-modification complex mSIN3/HDAC (ING2) (Barak et al., 2003; 
Shi et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Genome-wide distribution pattern of transcription-associated histone 
modifications. The distribution of histones and their modifications are mapped on an 
arbitrary gene relative to its promoter (5’ end), gene body, and 3’ end. With the 
exception of the data on K9 and K27 methylation, most of the data are based on yeast 
genes. (Adapted from Figure 1 (Li et al., 2007))  
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d. Histone PTMs & cell development 
Studies in yeast showed that mutations in H3K4, H3K36, or H3K79 result in relatively 
little growth defects. But the triple mutant on all the three residues (H3K4R / H3K36R 
/ H3K79R) is lethal by mitotic cell cycle delay and progressive transcription defect 
(Jin et al., 2007). Although the constitutive association between HMTs and mutated 
H3 may partially contribute to the lethality, the potential function of these PTMs in 
transcriptional regulation and cell growth can still not be excluded. 
More recently, genome-wide study in mammalian ESCs unveiled a unique 
association between H3 lysine methylation and ESC-specific gene expression. In 
ESCs, trimethylation modifications on both H3 K4 and K27 residue are found to co-
exist at many promoters and evolutionarily conserved sequences. These areas of 
chromatin are called “bivalent domains”, because K4me3 is a mark for activating 
chromatin, while K27me3 is a well-known repressive chromatin mark (Bernstein et al., 
2006). K4me3+K27me3 bivalent modifications are normally found in 
developmentally regulated genes, which are silenced in pluripotent ESCs but are 
activated upon differentiation. As a result, a combination of both K4me3 and K27me3 
modifications are proposed to poise genes in a “transcription-ready” state (Figure 9). 
This hypothesis brings an interesting connection between PTMs coupled 
transcriptional regulation and mammalian ESC development. But direct evidence is 
still missing to support this model. The precise function of these lysine methylations in 
mammalian transcriptional regulation and cell development still remains unknown. 
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Figure 9. Bivalent chromatin profiles in ESCs. In mammalian ESCs, the promoters 
of many non-transcribed developmental genes bear a combination of ‘conflicting’ 
histone modifications that are normally associated with either active chromatin states 
(H3K4me3, green) or inactive chromatin states (H3K27me, red). This indicates that 
these genes are ‘poised’ for expression in response to appropriate developmental cues. 
During differentiation, ‘bivalent’ chromatin profiles are generally resolved, leading to 
transcriptional activation of tissue-specific genes and silencing of loci associated with 
alternative developmental pathways. (Adapted from Figure 1 (Spivakov and Fisher, 
2007)) 
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2. Histone variant 
Except for H4, all the other core histones have variants. They are mostly encoded by 
single-copy genes located outside the histone gene clusters, and the protein sequences 
are very similar to their canonical counterparts. Interestingly, many histone variants 
have unique expression patterns, deposition mechanisms and genome localizations. 
The variations on a few critical residues are also proposed to cause nucleosome 
structural heterogeneity. Growing evidence is supporting the notion that histone 
variants, as histone PTMs, also contribute to the chromatin diversity and regulate 
many DNA-related events. (Pusarla and Bhargava, 2005)   
 
a. H3 variants (H3.3) 
Except for a centromere-specific H3 variant CENP-A, mammals have three somatic 
H3 variants, H3.1, H3.2, and H3.3 (Figure 10A). Among them, H3.1 and H3.2 are 
exclusively expressed and assembled into nucleosome during S phase in a replication-
dependent (RD) manner, while H3.3 is expressed in both proliferating and quiescent 
cells and is deposited in a replication-independent (RI) manner (Ahmad and Henikoff, 
2002; Szenker et al., 2011). Two independent chaperone systems facilitate H3.3 
incorporation into chromatin, with H3.3-specific chaperone HIRA responsible for 
deposition into protein-coding regions (Tagami et al., 2004; Goldberg et al., 2010), 
and the ATRX/DAXX complex responsible for deposition at repeat elements like 
telomeres and pericentric heterochromatin (Figure 10B) (Drané et al., 2010; Goldberg 
et al., 2010; Lewis et al., 2010).  
The “N-terminal tail” region in H3.3 is nearly identical to H3.1 and H3.2, with 
only one amino acid difference (Serine 31). Although this region is necessary for the 
deposition through RD pathway, it is dispensable for H3.3 specific RI deposition. 
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Comparing with H3.2, H3.3 also has three residues difference in the C-terminal 
structured region, which has been shown to be critical for its deposition through RI 
pathway (Figure 10A) (Ahmad and Henikoff, 2002). However, it is still unclear 
whether these differences in H3.3 can bring any structural diversity to chromatin. 
Unlike the other histone proteins, mammalian H3.3 is expressed from only two 
genes: H3f3a (H3.3A) and H3f3b (H3.3B) (Wellman et al., 1987). Gene trapping 
studies in mouse showed that H3.3A gene is ubiquitously expressed during early 
embryonic development and in many adult organs, and disrupting H3.3A gene results 
in partial neonatal lethality while surviving mutants display neuromuscular deficits 
(Couldrey et al., 1999). Expression of H3.3B gene is more tissue-specific. Targeted 
disruption of H3.3B gene in mouse is reported to be semilethal, and the surviving 
males are completely infertile with defects at different stages of spermatogenesis 
(Bush et al., 2013; Yuen et al., 2014).  
To distinguish H3.3 from the other H3 variants, our lab has generated mice that 
carry a HA epitope tag at the C-terminal of endogenous H3f3b gene (H3.3-HA) (Wen 
et al., 2014a; 2014c). Heterozygous H3.3-HA mice are viable and fertile. However, 
homozygous H3.3-HA mice are postnatally lethal with significantly low birth weight 
(Wen et al., 2014c). The cause of lethality is still under investigation. 
 
 
 
 
 
 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. H3 variants in somatic and embryonic mouse cells.  
(A) H3 variants. The amino acid differences and corresponding positions at the N-
terminal tail and the C-terminal structured regions are highlighted. RI, replication-
independent. RD, replication-dependent.  
(B) H3.3 enrichment and deposition pathways. In euchromatin, H3.3-specific HIRA 
complex is responsible for H3.3 deposition in the body of active genes and at 
promoters regardless of gene activity. In heterochromatin, the ATRX/DAXX 
complex is responsible for H3.3 deposition at pericentric heterochromatin and 
telomeres (ESC-specific). The chaperone complex that mediates H3.3 deposition 
at regulatory elements remains to be identified. (Modified from (Banaszynski et al., 
2010)) 
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b. H3.3 & Transcriptional Regulation 
Global analyses of Drosophila and mouse genomes showed that H3.3 is highly 
incorporated at the promoters, within the actively transcribed gene bodies, on the 
boundary of cis-regulatory elements, and at the telomere (Figure 10B) (Mito et al., 
2005; 2007; Wong et al., 2009). Some studies also reported that H3.3 is enriched in 
PTMs associated with active transcription, for example, K4me2, K4me3 and K36me2; 
but is deficient in PTMs marking gene silencing (McKittrick et al., 2004; Loyola et al., 
2006; Garcia et al., 2008). As a result, H3.3 is proposed to be a marker of active 
transcription in euchromatin regions (Hake and Allis, 2006). However, H3.3 region-
specific assembly may also cause structural changes in local chromatin, which may 
regulate corresponding gene expression and many other DNA-related events. This 
possibility is waiting to be confirmed or excluded. 
 
c. H3.3 & cell reprogramming  
H3.3 has been implicated in chromatin remodeling and epigenetic regulation of gene 
expression during various cell reprogramming processes (Banaszynski et al., 2010). 
In the early mouse zygote, maternal H3.3 plays an important role in male 
pronucleus formation (van der Heijden et al., 2005). The asymmetrical incorporation 
of H3.3 into the paternal genome is observed before the transcription activation in 
both the paternal and maternal pronuclei (Torres-Padilla et al., 2006). Recent studies 
also suggest that H3.3 deposition into the paternal genome is required for the 
enrichment of K27me3 modification and the establishment of pericentric 
heterochromatin, which ensure proper chromosome segregation during the first 
mitosis (Santenard et al., 2010).  
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Study in somatic cell nuclear transfer (SCNT) embryos also suggests that H3.3, 
but not H3.1/H3.2, is a maternal “reprogramming factor” that is essential for 
chromatin reorganization in the donor nucleus, resulting in pluripotency gene 
reactivation and reprogramming of a differentiated cell into the pluripotent state 
(Jullien et al., 2012; Wen et al., 2014a). 
Accumulating evidences suggest that H3.3 can assist mammalian stem cell 
differentiation and embryonic development. In mouse ESCs, H3.3 is suggested to be 
required for proper establishment of bivalent chromatin modification through 
faciliating PRC2 recruitment to developmental gene promoters. As a result, several 
lineage-specific genes are misregulated with reduced levels of K27me3 in H3.3-
depleted ESCs, resulting in alteration of the differentiation potency of ESCs 
(Banaszynski et al., 2013). It consists with the result that, although knocking out H3.3 
specific chaperon HIRA in mouse ESCs gives no observable effect, HIRA-/- mutant 
causes embryonic lethal at the gastrula stage (Roberts et al., 2002).  
 
 
 
 
 
 
 
 
 28 
III. Epigenetic Change in Mammalian Germ Cell 
Development 
 
1. Genome-wide epigenetic changes during PGC differentiation  
It is well known that PGCs undergo extensive epigenomic changes during their 
migration and early residence within the embryonic gonad. Immunohistochemistry 
study showed that at the time of PGC specification in post-implantation embryo 
(E7.25), several transcriptional repression-associated epigenetic marks are similar 
between PGCs and somatic cells (Seki et al., 2005; 2007). Subsequently, migrating 
PGCs erase genome-wide DNA methylation and H3K9me2 and then acquire high 
level of H3K27me3 by E9.5, which presumably complements the erasure of previous 
epigenetic marks to maintain a proper repressive chromatin state in PGCs (Figure 11) 
(Seki et al., 2007; Sasaki and Matsui, 2008). The global changes of transcriptional 
repression-associated epigenetic marks potentially play an important role in 
suppressing the somatic gene expression programme in migrating PGCs. Besides, the 
reprogramming on germ cell epigenome might restore and transmit totipotency into 
the zygote (Sasaki and Matsui, 2008). 
Extensive epigenetic reprogramming also occurs in post-migratory PGCs, as 
reflected by the genome-wide progressive erasure of parental imprints (E10.5 – E12.5) 
and establishment of paternal imprints (after E14.5), which are then maintained 
throughout the male germ cell development (Figure 11) (Davis et al., 1999; Ueda et al., 
2000; Li et al., 2004; Oakes et al., 2007). The epigenomic changes have been 
suggested to be important in activating PGC-specific genes (i.e., Ddx4, Sycp3, Dazl, 
etc.) in the genital ridge (Sasaki and Matsui, 2008). 
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Several recent studies applied chromatin immunoprecipitation and massively 
parallel sequencing (ChIP-Seq) to interrogate genome-wide epigenetic marks in PGCs 
at different developmental stages. Interestingly, K4me3+K27me3 bivalent histone 
modification was found at the promoters of many developmental regulatory genes in 
post-migratory PGCs (E11.5 and E12.5) (Lesch et al., 2013; Ng et al., 2013; Sachs et 
al., 2013). Transcription of these epigenetically ‘poised’ genes is repressed in PGCs 
but activated in somatic lineages to direct a wide range of cell differentiation. 
Furthermore, a significant percent of these PGC bivalent genes retain stable 
K4me3+K27me3 histone modification in both male and female germ cells following 
the sex determination (E13.5) and female meiosis (E14.5) (Lesch et al., 2013; Ng et al., 
2013; Sachs et al., 2013) 
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Figure 11. Epigenetic reprogramming during germ cell development in male 
mouse. Top, the major epigenetic events are listed chronologically. Bottom, Changes 
in epigenetic modifications or histone variant H3.3. The histone modification or 
protein level is labeled with light color for low level or dark color for high level, 
respectively. (Adapted and modified from Figure 1, 2 (Sasaki and Matsui, 2008)) 
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2. Spermatogonial epigenome 
Comparing to PGCs, epigenomic study is relatively limit in mammalian 
spermatogonia in postnatal testes. Immunohistochemical analysis of mouse testes 
showed that Plzf-expressing spermatogonia contain little H3K27me1 and H3K9me1/2, 
but H3K27me2/3 and H3K9me3 are detected as punctate foci (Payne and Braun, 
2006). Moderate H3K4me3 signal was also detected in Aundiff spermatogonia in adult 
mouse testes (Godmann et al., 2007). 
Due to the tiny amount of SSCs in adult mammalian testes, global in-depth 
analysis of the genetic and epigenetic profiles in SSCs is limited. Recently, Hammoud 
et al. isolated Thy-1+ and c-kit+ adult germline stem cells (AGSCs) from adult mouse 
testes with a magnetic cell sorting separator. These two cell populations were 
submitted to in-depth profiling on DNA methylation, histone modifications 
(H3K4me3 and H3K27me3), and gene expresssion (Hammoud et al., 2014). 
Interestingly, both Thy-1+ and c-kit+ AGSCs share highly similar epigenetic 
characteristics with ESCs and PGCs (E13.5), including promoter DNA methylation 
profiles and K4me3+K27me3 bivalent histone modification at many early embryonic 
gene promoters (Hammoud et al., 2014). This study provides new insights into germ 
cell biology and rises the interesting notion that developmental pluripotency could be 
preserved in epigenome and stably transmitted through germline development. 
However, Thy-1+ and c-kit+ AGSCs in this study can hardly represent Aundiff and Adiff 
spermatogonia in vivo, because both Thy-1 and c-kit are not restrict to spermatogonia 
but also expressed in many types of somatic cells. As a result, the AGSCs applied in 
this study were very likely to be contaminated by testicular stroma, and any 
conclusion derived from this result need to be validated on SSCs with high purity.  
Many studies including spermatogonial transplantation show that SSCs are 
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remarkably stable in long-term culture. Besides of the robust stem cell activity, SSCs 
retain the euploid karyotype and androgenetic DNA methylation pattern in imprinted 
genes for at least two years during in vitro expansion (Kanatsu-Shinohara et al., 2004; 
2005b; Imamura et al., 2006). The stable and robust proliferation makes SSC culture a 
nice tool for studying spermatogonial epigenome, as unlimit number of cells can be 
collected for biochemical experiment. However, evaluation of genome-wide 
epigenetic characteristics in SSC culture has not been reported. 
 
3. Genome-wide epigenetic changes during postnatal 
spermatogenesis 
Germ cells are subject to extensive chromosome reorganization and epigenomic 
changes during the various stages of spermatogenesis. Genome-wide changes were 
observed for H3K4me1/2/3 and H3K9me2 at meiotic prophase I, during chromosome 
pairing, double-strand break (DSB) formation and progression (Kota and Feil, 2010). 
Several studies indicate that these epigenetic transitions guide meiotic progression. For 
example, studies in S. cerevisiae (Borde et al., 2009), mice, and humans (Baudat et al., 
2010; Myers et al., 2010; Parvanov et al., 2010) implicate the role of H3K4me3 in 
DSB hotspots specification. However, the precise function of these epigenetic marks 
during meiosis is still not clear (Kota and Feil, 2010). 
After the second meiotic division, male mammalian germ cells develop into 
haploid round spermatids. Genome-wide histone-to-protamine exchange then replace 
most nucleosomal histones with protamines to generate transcriptionally inert 
spermatozoa with highly compact nuclei. However, many studies suggested that 
histone-bearing nucleosomes are retained in about 1–10% of the genome in mouse and 
human mature spermatozoa (Gatewood et al., 1987; Pittoggi et al., 1999). Moreover, 
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chromatin immunoprecipitation (ChIP) coupled with high-throughput sequencing 
revealed that the residual nucleosomes are highly enriched at CpG-rich sequences that 
lack DNA methylation (Erkek et al., 2013).  
Many transcription-associated histone modifications (i.e., H3K4me2/3, 
H3K27me3, etc.) enrich at loci of embryonic developmental importance in mature 
spermatozoa genome (Hammoud et al., 2009; Brykczynska et al., 2010). It is 
suggested that H3K4me3 and H3K27me3 histone modifications poise development 
genes in spermatozoa as well as in PGCs, pachytene spermatocytes or round 
spermatids, thus highlighting the maintenance of the bivalent state throughout the 
germline cycle (Figure 11) (Erkek et al., 2013; Lesch et al., 2013; Hammoud et al., 
2014; Lesch and Page, 2014). 
Besides of histone modifications, high level of histone variant H3.3 has also been 
identified in differentiating germ cells in adult mouse testes (Banaszynski et al., 2010). 
In Drosophila, H3.3 expression and deposition is observed in pre-meiotic germ cells, 
and increase dramatically during the first meiotic prophase when the majority of 
nuclear H3 is replaced by H3.3 (Akhmanova, AS et al. 1995). H3.3 incorporation is 
also detected at the XY body during meiotic sex-chromosome inactivation (MSCI) in 
mouse (van der Heijden et al., 2007). Our immunofluorescence (IF) experiment with 
H3.3-HA mouse testes also reveals significant H3.3 protein enrichment in post-
meiotic round spermatids (Figure 12). Furthermore, recent ChIP-seq result shows that 
residual nucleosomes in mouse spermatozoa are largely composed of H3.3 and K4me3 
modification (Erkek et al., 2013). These findings endow histones and corresponding 
modifications prime candidacies for epigenetic inheritance across generations.  
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Figure 12. Immunofluorescence with H3.3-HA mouse testes. Red, H3.3-HA. Blue, 
DAPI.  
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MATERIALS AND METHODS 
 
I. Experimental Procedures 
Mice 
The following mouse strains were applied to our study: Pou5f1-GFP JAXR (stock 
number 004654) (OG) (Szabó et al., 2002), C57Bl6 (B6), C57Bl6/129S (VG) 
(Seandel et al., 2007), H3.3-HA (Wen et al., 2014c), tetO-4F2A (Carey et al., 2010).  
 
Cell Culture 
Mouse SSCs 
Primary cultures of mouse SSCs were obtained and cultured as previously described 
(Seandel et al., 2007). In brief, mice over 3 months-old of the indicated genotypes 
were euthanized. Seminiferous tubules were collected from detunicated testes and 
minced on ice. The tissue was enzymatically dissociated with agitation for 30 minutes 
at 37 °C in a buffer containing 0.017% trypsin (Cellgro), 17mM EDTA (Cellgro), 
0.03% collagenase (Sigma-Aldrich), and DNase I (100 µg/ml; Sigma-Aldrich). The 
cell suspension was then collected and plated in gelatin coated plate in SSC medium 
containing StemPro-34 (Invitrogen) and supplements as follows: D(+) glucose, 6 
mg/ml; BSA, 0.50%; insulin, 25 µg/ml (Sigma-Aldrich); MEM nonessential amino 
acids, 1× (Gibco); MEM vitamin solution, 1× (Gibco); penicillin (100 
U/ml)/streptomycin (100 µg/ml)/amphotericin (0.2 µg/ml) (Media-tech); fetal bovine 
serum, 1%; L-glutamine, 2 mM (Media-tech); Bovine holo-transferrin, 100 µg/ml 
(Sigma-Aldrich); β-estradiol, 30 ng/ml (Calbiochem); progesterone, 60 ng/ml 
(Calbiochem); putrescine, 60 µM (Research Organics); sodium selenite, 30 nM 
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(Sigma-Aldrich); pyruvic acid, 30 µg/ml (Sigma-Aldrich); d(L)-lactic acid, 1 µg/ml 
(Baker); β-mercaptoethanol, 50 µM (Gibco); ascorbic acid, 100 µM (EMD); D-biotin, 
10 µg/ml (Calbiochem); human GDNF, 10 ng/ml (R&D Systems); human bFGF, 10 
ng/ml (Cell Signaling); mouse EGF, 20 ng/ml (R&D Systems). SSC colonies start to 
appear after about one week. The primary SSCs were then transferred to MEFs 
(Millipore #PMEF-CF) coated plate and expanded. After at least 10 passages, SSCs 
were collected by gentle trituration of colonies attached to feeder cells or floating in 
the medium. To remove residual feeder cells in the collection, SSCs were plated in 
gelatin-coated plates in fresh SSC medium for 2 hours. All the floating cells were then 
gently collected, washed once in PBS, and subjected to ChIP experiments or frozen for 
RNA isolation. 
ESCs, MASCs and iPS 
To establish MASC or iPS cell lines from corresponding primary reprogrammed cell 
culture, colonies with typical undifferentiatied ESC morphology were identified by 
phase microscopy and mechanically separated from the plate using Pasteur pipettes. 
The colonies were maintained using standard ESCs culture procedures. In brief, cells 
were all cultured with MEFs in standard ESC medium containing KnockOut DMEM 
(Gibco) and supplements as follows: KnockOut Serum Replacement, 10% (Gibco); 
penicillin (100 U/ml)/streptomycin (100 µg/ml)/amphotericin (0.2 µg/ml) (Media-
tech); L-glutamine, 2 mM (Media-tech); MEM nonessential amino acids, 1× (Gibco); 
β-mercaptoethanol, 50 µM (Gibco); ESGRO Leukemia Inhibitory Factor (LIF), 1000 
U/ml (Millipore). ESCs, MASCs, or iPS were serially passaged with trypsinization 
every 2 – 4 days onto fresh inactivated MEFs. All the cells applied for further 
experiments were collected within 20 passages.  
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ChIP and antibodies 
Chromatin immunoprecipitation (ChIP) was performed as previously described 
(Goldberg et al., 2010). Briefly, 1x107 cells per experiment were cross-linked for 
15min in 1% paraformaldehyde, washed and lysed. Chromatin was sheared using a 
Bioruptor to create fragments of approximately 150 base pairs, incubated with 
antibody overnight at 4 °C, then washed and eluted. The eluted chromatin was 
reverse-cross-linked and column purified. ChIP was performed using the following 
antibodies: H3K4me3 (Abcam ab8580), H3K27me3 (Abcam ab6002, Cell Signaling 
#9733), H3K27ac (Abcam ab4729), HA (12CA5 clone prepared by the MSKCC core 
facility). 
 
Sequence Library Construction and Sequencing 
ChIP samples were prepared for sequencing using Illumina TruSeq DNA Sample 
Preparation Kit according to the standard preparation protocol. RNA samples were 
prepared for sequencing using Illumina TruSeq RNA Sample Preparation Kit 
according to the standard preparation protocol (http://www.illumina.com/). 
Sequencing service was performed on an Illumina Hiseq 2000 sequencer according to 
the standard Illumina protocol.  
 
ChIP-qPCR 
ChIP DNA was diluted 1:100 in H2O and used for quantitative real-time PCR (qPCR) 
with 5 µL per reaction. ChIP-qPCR primers used were as follows: 
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Primer Sequence (5' -> 3') 
Oct4-ChIP-4F GGAACTGGGTGTGGGGAGGTTGTA 
Oct4-ChIP-4R AGCAGATTAAGGAAGGGCTAGGACGAGAG 
Oct4-ChIP-10F GGAGTCCCCTAGGAAGGCATTAATAGTTT 
Oct4-ChIP-10R GGATTCTCTCGGCTTCAGACAGACTTT 
Oct4-ChIP-12F CCCTTCCAGAGCCCCTTTCAGTAA 
Oct4-ChIP-12R GCACCAGGGTCTCCGATTTGCATA 
Oct4-ChIP-15F AGAGTTGGGAGCAGCCATGTAGGTT 
Oct4-ChIP-15R TGGCCTGTGGTGGTACATGACCTTA 
Ch8-ChIP-F AAGGGGCCTCTGCTTAAAAA 
Ch8-ChIP-R AGAGCTCCATGGCAGGTAGA 
Gata6-ChIP-F CCTTCCCATACACCACAACC 
Gata6-ChIP-R CCCCTCCTTCCAAATTAAGC 
Actin-ChIP-3F TTGATAGTTCGCCATGGATGACGA 
Actin-ChIP-3R ATCGATCCCCAAGAAAACCCCA 
Nanog-ChIP-4F TCTGCTGCCTAAGCTCTTGTGCTGT 
Nanog-ChIP-4R CTGCTCTTTCCAATCCCTTCTCCC 
HoxA1-ChIP-F TCACTGAGTGATTGGATCCTGC 
HoxA1-ChIP-R GGAGGAAGTGAGAAAGTTGGCAC 
HoxA2-ChIP-F GACAAGGTTGAAATTGGACCG 
HoxA2-ChIP-R CAAATTGTCATTGGGCAGAAGC 
HoxA4-ChIP-F CTCTGGAATAAAACGAAGGAGGC 
HoxA4-ChIP-R GGACAAAGAATCAAAGGGCGAG 
HoxA6-ChIP-F CTTTCCTTTTTTGCCTTCATGG 
HoxA6-ChIP-R TTGTCAGGTTTCCTGTTTGGG 
HoxA7-ChIP-F AACCCTTCCCCTAAACGCCTC 
HoxA7-ChIP-R AAAAGGTCGCCAGTCTTCCAG 
HoxA9-ChIP-F ATCTGTATGCCTAGTCCCGCTCC 
HoxA9-ChIP-R TTGATGTTGACTGGCGATTTTC 
HoxA10-ChIP-F CTGGCTCTTGAACCTGTACCCC 
HoxA10-ChIP-R CAAGGGTGCTTCCAAATAGTC 
HoxA11-ChIP-F GGAAGCAACAGATCGTCACTCG 
HoxA11-ChIP-R TGAGTTACACCGGCGATTACG 
HoxA13-ChIP-F CTATGACAGCCTCCGTGCTC 
HoxA13-ChIP-R CCCCTTCCATGTTCTTGTTG 
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II. Data Analytic Methods 
RNA-seq Data Processing and Analysis 
Reads from RNA-seq were aligned to mouse genome version mm9 using TopHat 
(Trapnell et al., 2009), and fragments per kilobase of transcript per million fragments 
mapped (FPKM) were identified using Cufflinks with upper-quartile and GC-
normalization (Trapnell et al., 2010). Duplicate reads and reads aligning to more than 
one location were excluded. Gene expression was reported as log2 
transformed FPKM value. 
Analyses applied in chapter I 
Genes with multiple isoforms and TSS were summarized for FPKM by common 
transcription start site (TSS) to get a total of 23,183 unique transcripts. Only genes 
within 2 (log2) fold change between two biological replicates of MASCs were 
considered to have consistent expression after reprograming; there were averaged 
based on expression values, and applied for subsequent analyses. Using this gene set, 
we selected all genes (3,316 unique transcripts) with expression differences of at least 
2 (log2) fold between any pair of the cell types, SSCs, MASCs, and ESCs. These gene 
expression values were used as input for hierarchical clustering (centered on gene, 
uncentered on cell type, centroid linkage) by Cluster 3.0 (de Hoon et al., 2004).  
Analyses applied in chapter II 
Genes with multiple isoforms and TSS were summarized for FPKM by common TSS 
to get a total of 24,033 unique transcripts. For genes with H3.3 replacement in exons, 
expression at each time point after induction was compared with that at day 0, and 
increase over 1 (log2) fold was considered as increased expression. Genes de novo 
activated in iPS were selected by over 2 (log2) fold increase in iPS than in MEFs (day 
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0), and expression in MEFs (day 0) is below 5 (log2 transformed FPKM value). There 
were 2,069 genes selected with these criteria as iPS activated genes. Genes remaining 
stable low expression in both MEFs and iPS were selected by within 1 (log2) fold 
change between MEFs (day 0) and iPS, and expression in MEFs (day 0) is below 5 
(log2 transformed FPKM value). Within 10,112 unique transcripts matching the 
criteria, 2,000 transcripts were randomly selected as iPS stable genes and subjected to 
further analyses. Expression changed genes during 10 days of reprogramming were 
selected as any gene with over 2 (log2) fold expression difference between any two 
time points from day 0 to day 10. All the rest were considered as stable expression 
genes during 10 days of reprogramming. 
 
ChIP-seq Data Processing and Analysis 
ChIP-seq reads were aligned to the reference mouse genome (mm9, NCBI Build 37) 
using the BWA program (Li and Durbin, 2009), and PCR duplicates were removed by 
Picard (http://picard.sourceforge.net/). Unique reads that mapped to a single best-
matching location with no more than 4% of the read length of mismatches were kept 
and used to study genome-wide enrichment of specific histone modification. Sequence 
data was visualized with IGV by normalizing to 1 million reads (Thorvaldsdóttir et al., 
2013). 
Analyses applied in chapter I 
The software ChIPseeqer 2.0 was applied to the ChIP-Seq data with sequencing data 
from input DNA as control to identify genomic enrichment (peak) of specific histone 
modifications (Giannopoulou and Elemento, 2011). Promoters were defined as +/- 2 
kb from transcription start site (TSS). The promoter chromatin state was determined 
by overlap with significant H3K4me3 and/or H3K27me3 peaks (t=5, with t as the 
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significance negative log p-value [ratio] threshold for peaks) (FDR<0.05). Promoter 
ChIP-seq Read Intensity ratio for histone Modification K4me3 and K27me3 (PRIMs) 
was calculated as !"#$ = !"#2 !!!"!!!!!"!"!!!, with K4me3 and K27me3 as average read 
counts from H3K4me3 and H3K27me3 sequences at the same promoter region and 
constant ‘a’ equals to 0.001. Only promoters with detectable K4me3 or K27me3 peaks 
were evaluated by PRIMs. 
An enhancer region was defined as any genomic locus with H3K27ac enrichment 
but no H3K4me3 enrichment (K27ac+K4me3-). To identify enhancer loci, K4me3 
peaks were extended 1 kb each way. All H3K27ac peaks not overlapping with 
extended H3K4me3 peaks, known gene body, transcription start (TSS) and end site 
(TES) were selected. Selected H3K27ac peaks within a 500 bp interval were merged 
together as enhancers. Enhancer regions from SSCs (OG), MASCs (OG), and ESCs 
(CMP10) were merged together. Each enhancer was annotated with all transcripts 
within a distance of 100 kb from TSS or TES. Any enhancer overlap with K27ac 
peaks in a given cell type was considered to be active in that cell type.  
Analyses applied in chapter II 
To study global H3.3 enrichment, we segmented the whole mouse genome into non-
overlapping 1kb windows, and calculated H3.3B-HA sequence read count per window 
with SNPseeqer developed in Dr. Elemento’s lab. Results from all selected cell types 
were compared by correlation clustering. To identify global H3.3 replacement sites 
during MEFs reprogramming, results between any time point after doxycycline 
induction and day 0 were compared, and genomic loci with over 2 folds read count 
increase (normalized by total read count of each sample) were selected as H3.3 
replacement sites. All H3.3 replacement sites were annotated to genome, with 
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genomic regions defined as: promoter, -2kb ~ TSS; TES, -2kb ~ 2kb around TES; 
distal region, over 2kb from transcript. 
To study H3.3B-HA and H3K27me3 enrichment at promoter and enhancer 
regions, we applied ChIPseeqer 2.0 developed in Dr. Elemento’s lab to calculate 
average sequence read count at selected loci, and reported as log2 transformed value 
(Giannopoulou and Elemento, 2011). Promoter was defined as -2 kb to transcription 
start site (TSS) of each transcript. Genomic loci with average read count at any time 
point after doxycycline induction higher than day 0 over certain cut-off (H3.3B-HA, 
0.15; H3K27me3, 0.2) are considered as increased with ChIP signals. Genomic loci 
with average H3K27me3 read count at day 0 higher than that at any time point after 
doxycycline induction over 0.2 are considered as decreased with H3K27me3 
modification. Genomic loci underwent both increase and decrease of H3K27me3 
during 10 days of reprogramming are considered as decreased with H3K27me3 
modification. In MEFs (day 0), promoter with low or high H3K27me3 is selected by 
below or above 0.2.  
To study promoters with ‘bivalent’ modification in ESCs, we applied ChIPseeqer 
2.0 to identify significant peaks (t=10) on H3K4me3 and H3K27me3 ChIP-seq 
dataset. The peaks were then annotated to promoter, which is defined as -2kb ~ 2kb 
around TSS as previousely described (Banaszynski et al., 2013). Promoters with both 
significant H3K4me3 and H3K27me3 peaks are considered as ESCs ‘bivalent’ 
promoters. 
To study enhancer regions potentially function in gene activation during 
reprogramming, we identified H3K27ac modified active enhancers in both MEFs and 
ESCs (adapted from Creyghton MP, et al., 2010). Significant H3K27ac peaks (t=5) 
were identified by ChIPseeqer 2.0, peaks from both MEFs and ESCs and within 500 
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bp distance were merged together, those located at least 2 kb away (edge to edge) 
from TSS and outside open reading frame were collected as enhancers potentially 
function in reprogramming. Enhancers within 100 kb distance from TSS or TES of a 
transcript were annotated to that gene.  
 
Gene Ontology Analysis 
Gene Ontology (GO) analysis was done using iPAGE with mouse GO annotation 
database (Goodarzi et al., 2009). 31,881 GO terms were examined. Only non-
electronic annotations were used in iPAGE and only categories with less than 300 
genes were analyzed. IPAGE uses randomized simulations to ensure FDR<5%. 
 
Motif Analysis 
Enrichment of known motifs within promoter and enhancer regions was analyzed with 
HOMER with default parameters and a fragment size of 200 bp. All known motifs 
used in our study were defined by HOMER (Heinz et al., 2010). 
 
Statistical Analysis 
Statistical Analysis was performed in R (version 3.1.0) statistical framework (R 
Development Core Team, 2008). R packages applied for analysis and graph include 
limma (3.20.8), gplots (2.14.1), ggplot2 (1.0.0), VennDiagram (1.6.7). 
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CHAPTER ONE 
 
DYNAMIC AND STABLE EPIGENETIC 
PROFILES SIGNIFY CELL FATE CONVERSION 
IN UNIPOTENT MOUSE SPERMATOGONIAL 
STEM AND PROGENITOR CELLS 
 
 
I. Summary 
Mammalian spermatogonial stem and progenitor cells (SSCs) are precursors of all 
subsequent germ cells in the adult male gonad. During in vitro expansion, these 
unipotent adult stem cells can spontaneously convert to multipotent adult 
spermatogonial-derived stem cells (MASCs) without ectopic expression of any 
transcription factors. The underlying mechanisms of this reprogramming event are still 
poorly understood. Here, We report an integrative analysis of both the transcriptomes 
and epigenomes of mouse SSCs and MASCs. We find in SSCs that many genes 
essential to maintenance and differentiation of embryonic stem cells (ESCs) are 
enriched with both histone H3 lysine 4 and lysine 27 trimethylation modifications 
(K4me3+K27me3) at promoter regions. Despite significantly increased expression 
after reprogramming, most of these genes maintain ‘bivalent’ promoter modification, 
with only a few ESCs pluripotency gene promoters selectively depleted of the 
K27me3 modification in MASCs. Quantitative epigenomic analysis further suggests 
that promoter histone modifications are restrictively changed at signature genes for 
ESCs and germ cells but remain repressive for most somatic genes, bestowing MASCs 
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with ESC-like promoter chromatin states. At enhancer regions, the core pluripotency 
circuitry is activated partially in SSCs and completely in MASCs, concomitant with 
global erasure of germ cell-specific enhancer activity and initiation of an embryonic-
like program. Furthermore, long-term in vitro cultured SSCs maintain epigenomic 
characteristics with germ cells in vivo. Our observations suggest that unipotent SSCs 
encode their innate developmental flexibility by means of the epigenome and that both 
the promoter chromatin state, and the activity of cell-type-specific enhancers is a 
prominent feature of SSC reprogramming.  
 
II. Introduction 
As the precursors of germ cells, mammalian spermatogonial stem and progenitor cells 
(SSCs) undergo unipotent differentiation in the adult male gonad, while still 
possessing the ultimate developmental potency to propagate across generations. 
During in vitro expansion, mouse SSCs, despite being unipotent, are uniquely capable 
of abrogating lineage commitment and spontaneously conversion to multipotent adult 
spermatogonial-derived stem cells (MASCs), which share many common features 
with pluripotent embryonic stem cells (ESCs), including the capacity to induce 
teratomas and contribute to chimeric animals (Figure 1A) (Kanatsu-Shinohara et al., 
2004; Li et al., 2007; Seandel et al., 2007). To date, this is the only known 
reprogramming event that converts unipotent adult stem cells back to a near 
pluripotent state without delivery of exogenous genes or gene products, which 
distinguishes it from formation of induced pluripotent stem (iPS) cells (Bernstein et al., 
2006; Takahashi and Yamanaka, 2006; Mikkelsen et al., 2007; Takahashi et al., 2007). 
These observations indicate that intrinsic genetic and epigenetic features rather than 
enforced expression of ectopic transcription factor(s) are responsible for 
 46 
reprogramming of SSCs. However, SSC conversion into MASCs is a rare event, and 
the underlying mechanisms remain largely unknown.  
One possible explanation for the spontaneous loss of lineage commitment is that 
SSCs may preserve a latent ESC-like gene expression program. Indeed, upon germline 
specification in the mouse embryo, somatic genes are mainly repressed in primordial 
germ cells (PGCs), while expression of several ESC signature transcription factors 
(e.g., Pou5f1/Oct4, Klf4, Esrrb) is reactivated and preserved at modest levels in SSCs 
in the adult testis (Pesce et al., 1998; Jaenisch and Young, 2008). Pou5f1/Oct4, 
together with Sox2 and Nanog, form the core pluripotency circuitry in ESCs to sustain 
stem cell self-renewal and control the expression of many differentiation genes (Boyer 
et al., 2005; Loh et al., 2006; Creyghton et al., 2010). As the precursors of all 
subsequent germ cells, SSCs also express spermatogenesis-specific genes (e.g., 
Zbtb16/Plzf, Piwil4) but repress regulators of somatic cell development (e.g., Prmt8) 
(Costoya et al., 2004; Carmell et al., 2007). 
Among other mechanisms that drive spontaneous conversion of SSCs into 
MASCs, the histone modification state plays a key role in transcriptional regulation 
and cell type specification (Goldberg et al., 2007; Surani et al., 2007). Extensive 
studies have shown that histone modifications are closely associated with 
transcriptional gene regulation. Notably, trimethylation on histone H3 lysine 4 
(K4me3) at promoters and acetylation on histone H3 lysine 27 (K27ac) at enhancers, 
respectively, correlate with gene expression, while Polycomb Repressive Complex 
2 (PRC2)-mediated trimethylation on histone H3 lysine 27 (K27me3) correlates with 
gene silencing (Li et al., 2007). In ESCs, K4me3 and K27me3 co-localize at promoters 
of many developmental genes that control stem cell differentiation to all somatic and 
germline lineages (Bernstein et al., 2006; Mikkelsen et al., 2007). Therefore, the 
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K4me3+K27me3 ‘bivalent’ modification is suggested to poise promoters in a 
repressive state, while the switch to a K4me3 or K27me3 univalent modification state 
is generally believed to direct gene activation or complete silencing, respectively, 
during stem cell differentiation (Jaenisch and Young, 2008). Enhancers also confer 
cis-regulation to gene expression by recruiting specific transcription factors, and 
enhancer activity is tightly controlled in a cell-type-specific manner (Creyghton et al., 
2010). The presence of the K27ac modification at genomic regions without the K4me3 
modification is considered to denote active enhancers, although it has also been 
reported that strong enhancers are marked by both K27ac and K4me3 modifications.  
Based on these observations, we hypothesize that the epigenetic landscape of SSCs 
is plastic and under certain as yet unrecognized conditions may cause conversion back 
to a ESC-like state. We performed transcriptome sequencing (RNA-seq) and found 
that MASCs are distinguished from SSCs by reactivation of somatic lineage-specific 
genes and silencing of spermatogenesis regulators. To elucidate the underlying 
molecular mechanisms, we performed chromatin immunoprecipitation and massively 
parallel sequencing (ChIP-Seq) on SSCs and MASCs to identify changes in histone 
modifications at both promoters and enhancers of reprogrammed genes. These 
genome-wide studies revealed that K4me3 and K27me3 co-localize to a significant 
number of developmental gene promoters in SSCs, and over two-thirds of these 
promoters are bivalent modified in both MASCs and ESCs. Notably, in MASCs, 
which function like pluripotent stem cells (e.g., in blastocyst chimerism), K27me3 is 
lost from genes crucial to early embryogenesis and stem cell maintenance but is 
increased at promoters of most germ cell-specific genes with potential gene-specific 
recruitment of the PRC2 (Suz12) complex. This dynamic epigenetic alteration closely 
correlates with gene expression changes and endows MASCs with ESC-like promoter 
chromatin states. At enhancer loci, we noted that the germ cell epigenetic “signature” 
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is largely lost in MASCs compared to SSCs, while ESC-specific enhancers are 
partially activated after reprogramming. Intriguingly, unipotent SSCs share substantial 
enhancer activity with multipotent MASCs and pluripotent ESCs. Indeed, active 
enhancers shared by SSCs and MASCs are predicted targets of many ESCs signature 
transcriptional regulators, including core pluripotency regulators such as Pou5f1/Oct4, 
Sox2, and Nanog. These transcription factors are also involved in de novo enhancer 
activation in MASCs. 
Taken together, our study provides global histone modification maps of mouse 
SSCs and MASCs, and reveals dynamic changes in epigenetic signatures before and 
after SSC reprogramming. These results offer new insight into transcription factor-
independent epigenetic regulation during mammalian cell reprogramming from a 
unipotent to a multipotent state and suggest several strategies to improve SSC 
reprogramming efficiency.  
 
III. Result 
1. SSCs, MASCs and ESCs share similar epigenomes 
We first compared global gene expression among SSCs, MASCs, and ESCs using 
hierarchical clustering of RNA-seq profiles collected from each of these cell types 
(Table 1.1). To ensure consistent transcriptional profiling, we selected two MASCs 
clones that efficiently form tri-lineage teratomas, a key criteria for pluripotency. These 
clones were isolated for RNA-seq. Consistent with previous studies, MASCs were 
transcriptionally similar to ESCs (Kanatsu-Shinohara et al., 2004; Seandel et al., 
2007). Moreover, in comparison with somatic multipotent stem cells (hematopoietic 
stem cells, HSCs), differentiated germ (round spermatids) or somatic (mouse 
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embryonic fibroblasts, MEFs) cells, SSCs were closely associated with MASCs and 
ESCs, irrespective of genetic background (Figure 1.1A). 
To investigate how the transcriptomes and epigenomes were coordinated for 
reprogramming of SSCs, we performed ChIP-Seq for histone modifications that are 
closely associated with transcriptional activation (K4me3, K27ac) and repression 
(K27me3) (Table 1.2). As expected, peak detection with ChIPseeqer-2.0 (FDR<0.05) 
(Giannopoulou and Elemento, 2011) revealed that both MASCs and ESCs were 
enriched with K4me3+K27me3 bivalent histone modifications at promoters of many 
developmental genes, an epigenetic signature of stem cell pluripotency (Figure 1.1B – 
F, Table 1.3, 1.4) (Mikkelsen et al., 2007). Notably, over 80% of the K27me3-marked 
promoters also possessed K4me3 modifications in SSCs (Figure 1.1C), and two-thirds 
(1,564/2,347) of these genes bearing bivalent modifications in SSCs were shared with 
MASCs and ESCs (Table 1.5); such genes regulate embryonic development into both 
germline and somatic lineages (Figure 1.1E, F).  
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Figure 1.1. SSCs, MASCs and ESCs share similar transcriptomes and promoter 
bivalency. 
(A) Dendrogram based on expression of all 23,183 protein-coding and noncoding 
genes. Green, multipotent or pluripotent stem cells. 
(B) Promoter categories basing on peak detection result from K4me3 and K27me3 
modifications. Green, K4me3 peak only. Red, K27me3 peak only. Yellow, both 
K4me3 and K27me3 peaks detected. Grey, no K4me3 or K27me3 peaks detected.  
(C) Percentage of K4me3+K27me3 bivalent promoters in K27me3 marked promoters. 
(D) GO enrichment in bivalent genes identified from different cell types. Red, over 
representation. Blue, under representation.  
(E) GO enrichment in bivalent genes shared or unique in SSCs, MASCs, and ESCs. +, 
promoter bivalency detected in certain cell type. 
(F) Overlap of bivalent promoters identified by peak detection in different cell types. 
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Notably, a significant number of bivalent genes in SSCs was transcriptionally 
activated, but not repressed, in MASCs (Figure 1.2, Table 1.5). This result suggests 
both that unipotent SSCs possess a plastic chromatin configuration characterized by 
bivalent histone modifications, a feature conserved with other cell types in a 
pluripotent developmental state, and that bivalent genes in SSCs are generally mainly 
poised for activation before converting to MASCs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. SSC bivalent genes are mainly activated in MASCs. 
(A) Comparison of global gene expression profiles between SSCs and MASCs. Black 
dots, peak detection identified SSC bivalent genes. 
(B) Percentage of genes with expression increase or decrease in MASCs. Black bar, 
peak detection identified SSC bivalent genes. Grey bar, genes modified with either 
K4me3, K27me3, or none of the two modifications in SSCs. 
 
To evaluate the relative abundance of these two histone modifications at the same 
genomic loci, we next quantified the ratio between K4me3 and K27me3 modifications 
at promoters with either or both peaks, referred to as the Promoter ChIP-seq Read 
Intensity ratio for histone Modification (PRIM) (see Methods). A PRIM cutoff that 
effectively distinguished K27me3-repressed promoters (PRIMlow, either 
K4me3+K27me3 or univalent K27me3) from active promoters (PRIMhigh, univalent 
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K4me3) was also identified for each cell type (Figure 1.3). Cluster analysis using 
PRIM values showed that MASCs and ESCs were close to each other in terms of 
K4me3- and K27me3-defined promoter chromatin states, and unipotent SSCs were 
closer to pluripotent cells than other cell types in this study (Figure 1.4). 
Thus, these results demonstrate that MASCs closely resemble ESCs with respect 
not only to global gene expression but also promoter histone modification and relative 
K4me3/K27me3 enrichments. Moreover, a significant pluripotency signature in the 
form of bivalent promoter modification is embedded in SSCs, the precursors of 
MASCs. By contrast, this pluripotency-associated epigenetic signature was less 
prevalent in other adult stem and differentiated cells that had been studied (Figure 
1.1B – D). 
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Figure 1.3. Distinguish active and repressed promoter chromatin states by 
PRIMs in (A) SSCs, (B) MASCs, and (C) ESCs. 
For each cell type, all promoters were assigned to each of the four chromatin state 
categories basing on peak detection result as in the bar graph (Left). Probability 
density distribution of PRIMs was made for each of the three states, K4me3 only, 
K4me3+K27me3, and K27me3 only (Middle). The cut-off value between K4me3 and 
K4me3+K27me3 or K27me3 groups was selected by the crossover between K4me3 
and K4me3+K27me3 plot. Y-axis, probability density. X-axis, PRIMs. Cut-off PRIM 
value, SSCs=2.5, MASCs=2.2, ESCs=2.2. Expression of genes in active (> PRIM cut-
off) and repressed (<= PRIM cut-off) promoter chromatin states is shown in boxplot 
(Right). Dashed line, median of all gene expression value. 
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Figure 1.4. Promoter histone modification correlation analysis with PRIMs. 
(A) Dendrogram based on PRIMs of all protein-coding/noncoding gene promoters. 
(B) Correlation of promoter PRIMs for all ChIP-seq datasets. Only promoters with 
detectable K4me3 or K27me3 were calculated for PRIMs. Correlation heat map 
was built basing on Pearson’s correlation coefficients between every pair of data.  
(C) Plot on PRIMs between MASCs and ESCs (up) or MASCs and SSCs (down) for 
all promoters. 
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Figure 1.4. Global promoter histone modification correlation analysis with PRIMs. 
(A) Dendrogram based on PRIMs of all protein-coding and noncoding gene promoters. 
(B) Correlation of promoter PRIMs for all ChIP-seq datasets. Only promoters with detectable K4me3 
or K27me3 were calculated for PRIMs. Correlation heat map was built basing on Pearson’s 
correlation coefficients between every pair of ChIP-seq data.  
(C) Plot on PRIMs between MASCs and ESCs (up) or SSCs (down) for all promoters. 
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2. SSC reprogramming involves activation of early embryonic genes 
and silencing of spermatogenesis-specific genes 
To elucidate the mechanisms underlying spontaneous reprogramming of SSCs, we 
then focused on 3,316 genes differentially expressed (>2-fold change) among SSCs, 
MASCs, and ESCs (Table 1.6). Hierarchical clustering assigned them into six classes 
as described below (Figure 1.5A).  
Over 90% (2,999/3,316) of the selected genes shared expression between MASCs 
and ESCs but differed from SSCs and were therefore considered as “reprogramming 
complete” genes (Figure 1.5A). Gene Ontology (GO) analysis showed that genes 
activated after reprogramming were mainly involved in ESC self-renewal and early 
embryonic development toward both somatic and germline lineages (e.g., 
Pou5f1/Oct4, Nanog, Fgf4, Class I) (Figure 1.5B, Table 1.6). Conversely, genes 
repressed in reprogrammed MASCs were enriched with regulators of germ cell 
differentiation and meiosis (e.g., Zbtb16/Plzf, Piwil4, Class II) (Figure 1.5B, Table 
1.6).  
The remaining 10% of the selected genes were not equally expressed in MASCs 
and ESCs. Among them, 211 “reprogramming incomplete” genes maintained similar 
expression between SSCs and MASCs but were relatively overexpressed (Class III) or 
repressed (Class IV) in ESCs (Figure 1.5A). Notably, a few transcription factors that 
function in mesoderm differentiation (e.g., Snai1, Ets1?Class IV) exhibited higher 
expression in MASCs but were repressed in ESCs (Figure 1.5B, Table 1.6). We also 
found a few genes uniquely overexpressed (Class V) or repressed (Class VI) in 
MASCs. In particular, Class V genes were significantly enriched with epithelial 
lineage regulators (e.g., Gata6, Wnt4) (Figure 1.5B, Table 1.6). Overexpression of 
these mesenchymal and epithelial signature transcription factors in MASCs could be 
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due to cell differentiation after long-term passage in culture and might bias the relative 
contribution to different germ layers during teratoma formation. Indeed, mesenchymal 
cells frequently differentiated from MASCs in my lab (data not shown), as reported 
also by other groups (Baba et al., 2007).  
In summary, SSC reprogramming involved induction of early embryonic genes 
that function in ESC self-renewal and differentiation to both somatic and germline 
lineages, while expression of spermatogenesis-specific genes was reduced in MASCs.  
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Figure 1.5. Differentially expressed genes among SSCs, MASCs, and ESCs. 
(A) Differential gene expression profiling among ESCs, MASCs, and SSCs. Genes 
with over two-fold (log2) difference between any pair of samples were selected 
and subjected to hierarchical clustering. Blue and white indicate relative higher 
and lower expression, respectively.  
(B) Gene ontology (GO) enrichment using iPAGE. Top: genes classified as in Figure 
1.5A. Dark blue, high expression. Light blue, low expression. Bottom, enrichment 
of GO biological functions in each gene class. Enrichment and depletion of certain 
GO functions (shown on the right) are measured by hypergeometric p-value 
(log10-transformed). The first column contains control genes that do not belong to 
any of the other 6 classes. Red and blue indicate relative over and under 
representation, respectively. 
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Figure 1.5. Differentially expressed genes among SSCs, MASCs, and ESCs. 
(A) Differential gene expression profiling among ESCs, MASCs, and SSCs. Genes with over two-fold 
(log2) difference between any pair of samples were selected and subjected to hierarchical clustering. 
Blue and white indicate relative higher and lower expression, respectively.  
(B) Gene ontology (GO) enrichment usi g iPAGE. Top: genes classified as in Figure 1G. Dark blue, 
high expression. Light blue, low expression. Bottom, enrichment of GO biological functions in each 
gene class. Enrichment and depletion of c rtain GO functions (shown on the right) are measured by 
hypergeometric p-value (log10-transformed). The first column contains genes that do not belong to any 
of the other 6 classes and is used as a contr l ge e list. Red and blue indicate relative over and under 
representation, respectively. 
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3. Bivalent promoter modification poises activation of somatic and 
ESC signature genes (Class I) in SSCs, with only a few switching to 
active chromatin states in MASCs 
We hypothesized that reprogramming of SSCs without enforced expression of 
transcription factors would be associated with concomitant chromatin changes. 
Therefore, we first investigated the promoter chromatin states of genes that are 
completely activated in MASCs (Class I) (Figure 1.5A, 1.6A). Strikingly, Class I gene 
promoters largely shared similar K4me3- and/or K27me3-marked chromatin states 
among SSCs, MASCs, and ESCs (Pearson's correlation=0.81) (Figure 1.6B – D). 
Despite significantly increased expression after SSC reprogramming, there were 
22.5% promoters possessed both K4me3 and K27me3 modifications in SSCs and 
MASCs (347 promoters, MASCStable I), including most of the bivalent promoters found 
in SSCs by peak detection (black dots, Figure 1.6D, 1.7A, Table 1.6). These 
MASCStable I genes mainly function in stem cell differentiation and embryonic organ 
development into somatic lineages (e.g., Esrrb, Prmt8) (Figure 1.6A, E, 1.7C). 
Conversely, only a small subset of Class I gene promoters acquired de novo 
modifications, K4me3 in particular, in MASCs (63 promoters, MASCM), or changed 
from repressive (SSCs) to active (MASCs) chromatin state with complete erasure of 
K27me3 (108 promoters, MASCActive) (Figure 1.6A, D, 1.7A, Table 1.6). MASCM and 
MASCActive subsets included many ESC signature genes associated with stem cell 
identity, e.g., Nanog (MASCM) and Zic3 (MASCActive) (Figure 1.6A, E, 1.7C). 
Compared to MASCStable I genes, MASCM and MASCActive genes were highly 
expressed in MASCs and ESCs, indicating a strong impact of chromatin state changes 
on transcriptional regulation (Figure 1.6A, 1.7B). These three types of gene clusters 
included the majority of the pluripotency and developmental regulators activated in 
MASCs (Figure 1.7C). 
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Figure 1.6. Promoter chromatin states on completely activated genes (Class I). 
(A) Expression profiling on example Class I genes. S, SSCs. M, MASCs. E, ESCs.  
(B) Chromatin states (PRIMs) of all Class I gene promoters. 
(C) Comparison of chromatin states (PRIMs) between ESCs and MASCs for all class I 
gene promoters. X-axis, PRIMs from ESCs. Y-axis, PRIMs from MASCs. r, 
correlation coefficient for all class I gene promoter PRIMs. 
(D) Comparison of chromatin states (PRIMs) between SSCs and MASCs for all class I 
gene promoters (grey dots). X-axis, PRIMs from SSCs. Y-axis, PRIMs from 
MASCs. Black dots, peak detection identified SSC bivalent genes. Red dots, Class 
I example genes displayed in Figure 1.6A. Dashed line, cut-off between activated 
(A) and repressed (R) chromatin states. r, correlation coefficient for all class I 
promoter PRIMs. Based on cut-off value, three groups of promoters were selected: 
MASCStable I, stably repressed in both SSCs and MASCs; MASCActive, repressed in 
SSCs but activated in MASCs; MASCM, not modified in SSCs but acquire either 
K4me3 or K27me3 modification in MASCs. 
(E) Promoter modification at selected genes. Top, expression class and promoter type 
of each gene. Green, K4me3 modification. Red, K27me3 modification. K4me3 
track range, 0 – 1. K27me3 track range, 0 – 0.5. 
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Figure 1.7. Promoter chromatin states, corresponding transcription activities, 
and biological functions on completely activated genes (Class I). 
(A) Histone modification enrichment profiling for selected class I gene promoters 
(grouped as in Figure 1.6D). Percentage of genes in each class is listed in brackets. 
Solid green, K4me3 in SSCs. Solid dark green, K4me3 in MASCs. Dashed dark 
green, K4me3 in ESCs. Solid red, K27me3 in SSCs. Solid dark red, K27me3 in 
MASCs. Dashed dark red, K27me3 in ESCs. TSS, transcription start site. Arrow, 
direction of transcription. X-axis, distance to TSS. Y-axis, average read density. 
(B) Transcription activities in selected subsets of Class I genes. Genes are grouped by 
promoter PRIMs as in Figure 1.6D. **, p-value < 0.01. 
(C) GO enrichment using iPAGE. Genes are grouped by promoter PRIMs as in Figure 
1.6D. A, active chromatin state. R, repressive chromatin state. M, detectable 
histone modification (K4me3 or K27me3). N, undetectable histone modification 
(K4me3 or K27me3). Bottom, number of genes in each group. 
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Therefore, dynamic chromatin state changes were restricted to only a few ESC 
signature genes (Class I, MASCActive and MASCM), indicating that promoter 
chromatin state-associated transcriptional activation is both selective and gene 
specific. However, genes functioning in embryonic differentiation to somatic lineages 
maintained their bivalent promoter modifications in both SSCs and MASCs, 
consistent with recent observations of freshly isolated mouse spermatogonia 
(Hammoud et al., 2014). Expression of such genes during SSC reprogramming could 
be regulated by mechanisms that do not affect promoter histone modifications, e.g., 
transcription factor binding at cell-type-specific enhancers.   
 
4. Germ cell-specific genes (Class II) are repressed in MASCs with a 
general increase in promoter K27me3 modification 
In contrast to Class I, Class II included 1,458 genes that were highly expressed in 
SSCs but down-regulated in MASCs and ESCs (Figure 1.5A, 1.8A). Correspondingly, 
most Class II promoters shifted from an active towards a more repressive chromatin 
state after reprogramming (Figure 1.8B). In particular, there were 40.9% promoters 
modified with concomitant de novo K27me3 and decreased K4me3 marks in MASCs 
(596 promoters, MASCRepress), encompassing nearly three-fourths of Class II 
promoters that were epigenetically active in SSCs (Figure 1.8D, 1.9A, Table 1.6). 
Significant K27me3 increases were also observed at 14.8% promoters that preserved 
both repressed chromatin states and relatively low expression in both SSCs and 
MASCs (216 promoters, MASCStable II) (Figure 1.8D, 1.9A, B, Table 1.6). These 
transcriptionally poised genes (MASCRepress and MASCStable II) typically regulate 
embryonic differentiation toward germline and ectoderm lineages (e.g., Zbtb16/Plzf, 
Dmbx1) (Figure 1.8E, 1.9C). Furthermore, many spermatogenesis regulators exhibited 
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substantial reductions in the K4me3 mark, yielding unmodified promoter chromatin in 
MASCs (e.g., Piwil4) (MASCNM) (Figure 1.8, 1.9, Table 1.6). MASCNM genes were 
generally silenced beyond the average Class II genes in MASCs (Figure 1.9B). 
Notably, many genes with promoter bivalent modifications in SSCs (MASCActive, 
MASCStable I, MASCStable II) lost either K4me3 or both marks in other somatic stem or 
differentiated cells, but K4me3 modifications were typically preserved in round 
spermatids, the precursor of mature spermatozoa (Figure 1.8E). 
Thus, the majority of somatic genes with bivalent promoter modifications in SSCs 
remained epigenetically repressed in MASCs, despite transcriptional activation 
(MASCStable I) or repression (MASCStable II) after reprogramming. However, most ESC 
signature genes and germ cell-specific genes underwent dynamic changes in promoter 
K27me3 modification, while a few of them either acquired or erased K4me3 
modifications in MASCs. These two histone modifications significantly affected the 
promoter chromatin states of a small subset of transcriptionally activated genes (Class 
I), but more prominently affected the repressed genes (Class II).  
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Figure 1.8. Promoter chromatin states on completely repressed genes (Class II). 
(A) Expression profiling on example Class II genes. S, SSCs. M, MASCs. E, ESCs.  
(B) Chromatin states (PRIMs) of all Class II gene promoters. 
(C) Comparison of chromatin states (PRIMs) between ESCs and MASCs for all class 
II gene promoters. X-axis, PRIMs from ESCs. Y-axis, PRIMs from MASCs. r, 
correlation coefficient for all class II gene promoter PRIMs. 
(D) Comparison of chromatin states (PRIMs) between SSCs and MASCs for all class 
II gene promoters (grey dots). X-axis, PRIMs from SSCs. Y-axis, PRIMs from 
MASCs. Black dots, peak detection identified SSC bivalent genes. Red dots, Class 
II example genes displayed in Figure 1.8A. Dashed line, cut-off between activated 
(A) and repressed (R) chromatin states. r, correlation coefficient for all class II 
gene promoter PRIMs. Based on cut-off value, three groups of promoters are 
selected: MASCStable II, stably repressed in both SSCs and MASCs; MASCRepress, 
activated in SSCs but repressed in MASCs; MASCNM, lose all detectable 
modifications in MASCs. 
(E) Promoter modification at selected genes. Top, expression class and promoter type 
of each gene. Green, K4me3 modification. Red, K27me3 modification. K4me3 
track range, 0 – 1. K27me3 track range, 0 – 0.5. 
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Figure 1.9. Promoter chromatin states, corresponding transcription activities, 
and biological functions on completely repressed genes (Class II) in SSCs, 
MASCs, and ESCs. 
(A) Histone modification enrichment profiling for selected class II gene promoters 
(grouped as in Figure 1.8D). Percentage of genes in each class is listed in brackets. 
Solid green, K4me3 in SSCs. Solid dark green, K4me3 in MASCs. Dashed dark 
green, K4me3 in ESCs. Solid red, K27me3 in SSCs. Solid dark red, K27me3 in 
MASCs. Dashed dark red, K27me3 in ESCs. TSS, transcription start site. Arrow, 
direction of transcription. X-axis, distance to TSS. Y-axis, average read density. 
(B) Transcription activities in selected subsets of Class II genes. Genes are grouped by 
promoter PRIMs as in Figure 1.8D. **, p-value < 0.01. 
(C) GO enrichment using iPAGE. Genes are grouped by promoter PRIMs as in Figure 
1.8D. A, active chromatin state. R, repressive chromatin state. M, detectable 
histone modification (K4me3 or K27me3). N, undetectable histone modification 
(K4me3 or K27me3). Bottom, number of genes in each group. 
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5. Incompletely reprogrammed genes (Class III, IV) and MASC-
specific genes (Class V, VI) achieve ESC-like promoter chromatin 
states 
In addition to completely reprogrammed genes, we also identified genes that stayed 
silent (Class III) (Figure 1.5A, 1.10A, B) or were consistently expressed (Class IV) 
(Figure 1.5A, 1.10E, F) in both SSCs and MASCs in contrast to ESCs (Table 1.6). 
Each class constituted only ~3% genes in this study. Surprisingly, these incompletely 
reprogrammed genes shared similar promoter chromatin states between MASCs and 
ESCs (Figure 1.10C, D, G, H). In particular, the K27me3 modification was 
significantly enriched at Class IV promoters in both MASCs and ESCs but not in 
SSCs, suggesting that these promoters switched from an active to a poised chromatin 
state prior to completion of transcriptional repression (Figure 1.10G, H). 
An ESC-like promoter chromatin state was also observed at most MASC-specific 
overexpressed (Class V) (Figure 1.11A – D) or silenced (Class VI) genes (Figure 
1.11E – H). Notably, many mesoderm-specific genes (e.g., Snai1, Class IV; Sox7, 
Class V) and epithelial-specific genes (e.g., Gata6, Class V) acquired not only high 
expression but also bivalent promoter modifications in MASCs (Figure 1.10E, I, 
1.11A, I), indicating that transcription of such genes could be easily adjusted by a 
change in chromatin modification.  
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Figure 1.10. Incompletely reprogrammed genes (Class III, IV) achieve ESC-like 
promoter chromatin states. 
Expression profiling on example (A) Class III or (E) Class IV genes among SSCs (S), 
MASCs (M), and ESCs (E). Associated differentiation lineages are shown to the right. 
Expression profiling of all (B) Class III or (F) Class IV genes. Dashed line: average 
expression of all genes in each cell type. 
Promoter PRIMs profiling of all (C) Class III or (G) Class IV genes. Dashed line: 
average promoter PRIMs of all genes in each cell type. 
Histone modification enrichment profiling for all (D) Class III or (H) Class IV gene 
promoters. 
(I) Promoter modification at selected genes. Top, expression class and promoter type 
of each gene. Green, K4me3 modification. Red, K27me3 modification. K4me3 track 
range, 0 – 1. K27me3 track range, 0 – 0.5. 
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Figure 1.11. MASC-specific genes (Class V, VI) achieve ESC-like promoter 
chromatin states. 
Expression profiling on example (A) Class V or (E) Class VI genes among SSCs (S), 
MASCs (M), and ESCs (E). Associated differentiation lineages are shown to the right. 
Expression profiling of all (B) Class V or (F) Class VI genes. Dashed line: average 
expression of all genes in each cell type. 
Promoter PRIMs profiling of all (C) Class V or (G) Class VI genes. Dashed line, 
average promoter PRIMs of all genes in each cell type. 
Histone modification enrichment profiling for all (D) Class V or (H) Class VI gene 
promoters. 
(I) Promoter modification at selected genes. Top, expression class and promoter type 
of each gene. Green, K4me3 modification. Red, K27me3 modification. K4me3 track 
range, 0 – 1. K27me3 track range, 0 – 0.5. 
1.0 1.5 2.0 2.5 3.0
?
2
0
2
4
6
8
SSC_OG.prim ESC_MTS07.prim
?
2
0
2
4
6
8
P
R
I M
s
S        M        E 
Promoter State 
1.0 1.5 2.0 2.5 3.0
0
2
4
6
8
1 0
SSC_OG rna ESC_OG.rna
0
2
4
6
8
1 0
l o
g 2
 F
P
K
M
S        M        E 
Gene Expression Class V 
S  M  E 
Lama1 
Tgfb1i1 
Gata6 
Wnt4 
Bmp2 
Sox7 
Dkk1 
Epithelia 
 
 
 
Mesoderm 
?4000 ?2000 0 2000 40000 .
0
0 . 5
1 . 0
1 . 5
A v e
r a g
e  R
e a d
 D e
n s i
t y
0 . 0
0 . 5
1 . 0
1 . 5
0 . 0
0 . 5
1 . 0
1 . 5
?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v e
r a g
e  R
e a d
 D e
n s i
t y
0
2
4
6
8
1 0
0
2
4
6
8
1 0 K4me3  
 
 
 
 
 
K27me3 
10 
 
 
 
0 
 
1.5 
 
 
 
0 
-4      -2       0        2       4 
TSS 
?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v
e r
a g
e  
R e
a d
 D
e n
s i t
y SSPCs
MASCs
ESCs
SSCs 
M  
ES  ?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v
e r
a g
e  
R e
a d
 D
e n
s i t
y SSPCs
MASCs
ESCs
SSCs 
MA  
ES  
A                                      B                              C                            D 
1.0 1.5 2.0 2.5 3.0
?
2
0
2
4
6
8
SSC_OG.prim ESC_MTS07.prim
?
2
0
2
4
6
8
P
R
I M
s
Promoter State 
S        M        E 
1.0 1.5 2.0 2.5 3.0
0
2
4
6
8
1 0
SSC_OG rna ESC_OG.rna
0
2
4
6
8
1 0
l o
g 2
 F
P
K
M
S        M        E 
Gene Expression Class VI 
S  M  E 
Hormad1 
Rhox1 
Nxf3 
Nme5 
Rpl29 
Xlr3c 
Pnma3 
Fgr 
Germ Cells 
 
-
1
.
5
0
 
 
-
1
.
1
7
 
 
-
0
.
8
3
 
 
-
0
.
5
0
 
 
-
0
.
1
7
 
 
0
.
1
7
 
 
0
.
5
0
 
 
0
.
8
3
 
 
1
.
1
7
 
 
1
.
5
0
 
Expression 
Low                         High 
?4000 ?2000 0 2000 40000 .
0
0 . 5
1 . 0
1 . 5
A v e
r a g
e  R
e a d
 D e
n s i
t y
0 . 0
0 . 5
1 . 0
1 . 5
0 . 0
0 . 5
1 . 0
1 . 5
?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v e
r a g
e  R
e a d
 D e
n s i
t y
0
2
4
6
8
1 0
0
2
4
6
8
1 0 K4me3  
 
 
 
 
 
K27me3 
10 
 
 
 
0 
 
1.5 
 
 
 
0 
-4      -2       0        2       4 
TSS 
?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v
e r
a g
e  
R e
a d
 D
e n
s i t
y SSPCs
MASCs
ESCs
SSCs 
M  
ES  ?4000 ?2000 0 2000 4000
0
2
4
6
8
1 0
A v
e r
a g
e  
R e
a d
 D
e n
s i t
y SSPCs
MASCs
ESCs
SSCs 
MA  
ES  
E                                      F                              G                            H 
Snai1 Zbtb16/Plzf Lax1 Gata6 Prmt8 Nanog Zic3 Piwil4 Dmbx1 
SSCs 
 
MASCs 
 
ESCs 
 
MEFs 
 
HSCs 
 
RS 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
Class I 
MASCActive               MASCM                MASCStable I 
Class II 
MASCRepress               MASCNM               MASCStable II 
Class III Class IV Class V 
5 kb 
Gata6 Ets1 
Snai1 Ets1 Gata6 Sox7 
SSCs 
 
 
MASCs 
 
 
ESCs 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
10 kb 
Class IV Class V 
Snai1 Zbtb16/Plzf Lax1 Gata6 Prmt8 Nanog Zic3 Piwil4 Dmbx1 
SSCs 
 
MASCs 
 
ESCs 
 
MEFs 
 
HSCs 
 
RS 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
Class I 
MASCActive               MASCM                MASCStable I 
Class II 
MASCRepress        MASCNM               MASCStable II 
Class III Class IV Class V 
5 kb 
Gata6 Ets1 
Snai1 Ets1 Gata6 Sox7 
SSCs 
 
 
MASCs 
 
 
ESCs 
K4me3 
K27me3 
K4me3 
K27me3 
K4me3 
K27me3 
10 kb 
Class IV lass I 
 73 
6. MASCs are depleted of germ cell-specific enhancer activity but 
partially enriched for ESC enhancers 
To investigate the mechanisms of incomplete reprogramming (Class III, IV) and 
MASC-specific gene expression (Class V, VI), we extended our analysis of epigenetic 
regulation beyond promoters by using H3K27ac (K27ac) ChIP-seq, which detected 
active enhancers defined as regions with K27ac peaks but without known promoters or 
K4me3 peaks (K27ac+/K4me3-).  
A total of 9,738 enhancers were found to be active in at least one of the three cell 
types (SSCs, MASCs, ESCs) and were associated with the 3,316 differentially 
expressed genes (Table 1.7). As predicted, MASCs, having lost lineage commitment, 
shared more active enhancers with pluripotent ESCs (1,582, ME enhancers) than with 
unipotent SSCs (194, SM enhancers) (Figure 1.12A, B). Of note, one-third of 
enhancers activated in both MASCs and ESCs were also active in SSCs (803, SME 
enhancers) (Figure 1.12A). DNA motif search with the HOMER computer program 
revealed that many ESC signature transcription factors (e.g., Sox2, Nr5a2) could bind 
at these common active enhancers, indicating that an ESC-like transcriptional program 
might be partially active in SSCs (Figure 1.13, Table 1.8). Conversely, the 3,107 ESC-
specific enhancers were targeted by many late embryogenesis regulators (e.g., Usf1/2, 
Foxh1), suggesting that the ESC differentiation apparatus could be responsible for 
activation of such enhancers (Figure 1.13). Study of ChIP-seq data sets in ESCs 
confirmed that ME and SME enhancers near the ESCs active genes (e.g., Zic3, Nanog 
in Class I; Lax1 in Class III) were highly occupied by many ESC signature 
transcription factors, particularly those centered at pluripotency circuitry 
(Pou5f1/Oct4, Sox2, Nanog) (Figure 1.14, 1.15, Table 1.7). However, not many ESC- 
or SSC-specific enhancers were targets of core pluripotency transcription factors 
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(Figure 1.14, 1.15). Only Esrrb and Tfcp2l1 were found at ESC-specific enhancers 
(e.g., Gata6, Class V), consistent with their roles in establishing gold standard, ESC-
defined pluripotency (Figure 1.14, 1.15).  
There were little unique motif enrichment at the 1,336 MASC-specific enhancers, 
except for Atf3, Prdm14, Smad3, and NFkB signaling factors, which could play roles 
in MASC formation (Figure 1.13, Table 1.8). Considering their relative dominance 
near Class V genes, MASC-specific enhancers could promote overexpression of those 
genes (Figure 1.12C). Furthermore, we also identified a group of enhancers active in 
SSCs that were silent in MASCs but active in ESCs (552; referred to as SE 
enhancers); many were associated with genes suggestive of incomplete 
reprogramming in MASCs (e.g., Snai1, Class IV) (Figure 1.15). Motifs enriched at 
both SSC-specific enhancers (e.g., ETS, FOX families) and ESC-specific enhancers 
(e.g., Zfx) were identified in these SE enhancers (Figure 1.13, Table 1.8); some SE 
enhancers were also occupied by core pluripotency transcription factors in ESCs 
(Figure 1.15). Such a pattern could indicate that a switch from germ cell-type 
transcriptional regulation to pluripotency circuitry occurs concomitant with SSC 
reprogramming and that incomplete establishment of ESC-specific enhancer activity 
could delay reprogramming at a small percent of genes. 
In summary, MASCs exhibited erasure of germline-specific enhancers and 
partially established enhancers that resemble those of ESCs. This process was 
prospectively enabled by binding of ESCs signature transcription factors. This switch 
of enhancer activity closely correlated with changes in expression of nearby genes and 
could support SSC reprogramming along with changes in promoter chromatin state. 
ESC-specific enhancers that remained silent in MASCs would not affect cell 
differentiation to different lineages. 
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Figure 1.12. Enhancer activity at different classes of genes in SSCs, MASCs, and 
ESCs. 
(A) Overlap of active enhancers in SSCs, MASCs, and ESCs. 
(B) Percentage of enhancers near Class I ~ VI genes. S enhancer, enhancers active 
only in SSCs. SM enhancer, enhancers active in SSCs and MASCs. E enhancer, 
enhancers active only in ESCs. ME enhancer, enhancers active in MASCs and 
ESCs. 
(C) Percentage of enhancers near Class I ~ VI genes. M enhancer, enhancers active 
only in MASCs. SE enhancer, enhancers active in SSCs and ESCs. Brown dashed 
line, percentage of M enhancer near all genes. Blue dashed line, percentage of SE 
enhancer near all genes. 
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Figure 1.13. Enrichment of transcription factor binding motifs for class I ~ VI 
gene promoters (left) and enhancers active (+) or silence (-) in different cell types 
(right). Each row represents a motif, and the corresponding transcription factors are 
labeled on the side. Red, genes up-regulated (Class I, III) in ESCs. Blue, genes down-
regulated (Class II, IV) in ESCs. 
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Figure 1.13. Enrichment of transcription factor binding motifs for promoters of 
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(right). Each row represents a motif, and the corresponding transcription factors are labeled 
on the side. Red, genes up-regulated (Class I, III) in ESCs. Blue, genes down-regulated (Class 
II, IV) in ESCs. 
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Figure 1.14. Enrichment of transcription factors at promoters and associated 
enhancers in ESCs. Promoters were grouped by expression class as in Figure 1.5A 
and chromatin state as in Figure 1.6D, 1.8D. Dark orange, core pluripotency 
transcription factors. 
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Figure 1.15. K27ac modification (blue) and transcription factor enrichment in 
ESCs (black) at selected genes. a, Zic3 (Class I, MASCActive). b, Nanog (Class I, 
MASCM). c, Prmt8 (Class I, MASCStable I). d, Zbtb16 (Class II, MASCRepress). e, Piwil4 
(Class II, MASCNM). f, Dmbx1 (Class II, MASCStable II). g, Lax1 (Class III). h, Snai1 
(Class IV). i, Gata6 (Class V). Red region, promoters. Blue bar at bottom, enhancer 
region. E, enhancers activated only in ESCs. ME, enhancers activated in both MASCs 
and ESCs. SME, enhancers activated in SSCs, MASCs and ESCs. SE, enhancers 
activated in both SSCs and ESCs. S, enhancers activated only in SSCs. All track 
range, 0 – 1. 
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7. Expression of somatic genes with promoter bivalency is potentially 
balanced by PRC2 (Suz12) and cell-type-specific transcription 
factors 
To elucidate the molecular mechanisms involved in transcriptional regulation and 
changes in promoter chromatin state, we also applied DNA motif search with HOMER 
to the transcriptionally-defined promoter classes. Notably, transcriptionally activated 
promoters (Class I) were specifically enriched for motifs of many Class I stem cell 
pluripotency regulators (e.g., Pou5f1/Oct4, Sox2, Nanog, c-Myc), whereas repressed 
promoters (Class II) were preferential targets of ESC differentiation regulators that 
lost expression in MASCs (e.g., FOX family, Rfx3, Class II) (Figure 1.13, Table 1.8). 
However, promoters of class III ~ VI were not significantly enriched for such motifs 
(Figure 1.13). This analysis indicated that completely reprogrammed genes could be 
auto-regulated by their own classes of transcripts. This notion was supported by 
comparison with published ChIP-seq data sets, showing that core pluripotency 
transcription factors generally bind to completely activated Class I promoters in ESCs 
(Figure 1.14, 1.15) (Chen et al., 2008; Heng et al., 2010). Therefore, we suggest that 
SSC reprogramming requires recruitment of distinct transcription factors that control 
gene activation and repression at promoter regions and that this regulation is likely 
critical to complete reprogramming. 
Analysis of ChIP-seq data also revealed that the PRC2 subunit Suz12 was enriched 
at promoters with K27me3 modification in ESCs. Most of these promoters lacked 
binding motifs of core pluripotency transcription factors, except for some somatic 
genes that maintained promoter bivalency but were up-regulated in MASCs (e.g., 
Prmt8, Class I, MASCStable I) (Figure 1.14, 1.15). Binding of core pluripotency 
transcripts at epigenetically poised promoters could improve the expression of these 
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somatic genes without altering their underlying promoter chromatin states. By 
contrast, very few core pluripotency transcription factors were found at bivalent 
promoters that were down-regulated in MASCs and ESCs (e.g., Dmbx1, Class II, 
MASCStable II) (Figure 1.14, 1.15). Instead, such bivalent promoters were targets of 
multiple regulators of embryonic differentiation, many of which show decreased 
expression in MASCs (e.g., ETS, FOX families) (Figure 1.13). Taken together, these 
data suggest that transcription of down-regulated bivalent promoters (MASCStable II) 
are controlled by such differentiation factors that are expressed in SSCs and become 
silent during SSC reprogramming, thereby down-regulating target promoters in 
MASCs. In MASCs. Polycomb-mediated repression could dominate the promoters of 
such lineage-specific genes in MASCs and reinforce the developmental flexibility.  
In summary, these findings suggest that bivalently modified somatic gene 
promoters could be regulated by both PRC2(Suz12) and target-specific transcription 
factors and that their cooperation drives active transcription or silencing of these 
genes, respectively, in a cell-type-specific manner. 
 
8. SSCs retain promoter bivalency comparable with germ cells in 
vivo. 
Recently, genome-wide studies of the germline epigenome revealed that the 
K4me3+K27me3 bivalent histone modification remains faithfully stable from the 
development of embryonic progenitors through to postnatal germ cells (Lesch et al., 
2013; Ng et al., 2013; Sachs et al., 2013). Besides germ cell-specific genes, many 
developmental regulators functioning in somatic lineages are poised with both K4me3 
and K27me3 histone modifications at promoters in PGCs (Lesch et al., 2013; Ng et al., 
2013), adult germline stem cells (AGSCs) (Hammoud et al., 2014), pachytene 
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spermatocytes (Lesch et al., 2013; Hammoud et al., 2014), round spermatids (Erkek et 
al., 2013; Lesch et al., 2013; Hammoud et al., 2014), and mature spermatozoa 
(Hammoud et al., 2014). This epigenetic feature is therefore suggested to be essential 
for germ cell identity and function (Lesch and Page, 2014). To understand whether 
long-term in vitro cultured SSCs preserve similarly poised chromatin as do germ cells 
in vivo, we compared K4me3 and K27me3 ChIP-seq results from cultured SSCs with 
those of published data. 
We focused on 2,347 SSC bivalent genes, which were selected by peak detection 
as genes with significant K4me3 and K27me3 marks at promoters in at least two SSC 
cell lines (Table 1.5). Cluster analysis using PRIM values for these promoters showed 
that, cultured SSCs not only shared similar K4me3- and K27me3-defined chromatin 
states with cultured MASCs and ESCs but also with PGCs directly isolated from 
embryonic gonads (E12.5 – E14.5) (Lesch et al., 2013). However, multiple types of 
progenitors or differentiating germ cells isolated from adult testes were relatively 
distant from SSCs, similar as somatic stem or differentiated cells applied in this study 
(Figure 1.16A). We next investigated dynamic changes in histone modifications at 
each promoter within the germline lineage. With k-means clustering function in 
seqMINER (Ye et al., 2011), SSC bivalent genes were grouped according to similarity 
of promoter K4me3 and K27me3 profiles in PGCs (E12.5, E13.5, E14.5), AGSCs, 
pachytene spermatocytes, round spermatids, and mature spermatozoa (Figure 1.16B, 
Table 1.5). Intriguingly, there were 358 genes (cluster I) that maintained relatively 
high K4me3 and K27me3 signals from PGCs to spermatozoa (Figure 1.16B, C). The 
increase in K27me3 modification was initiated as early as E13.5 in PGCs, the time 
point of sex determination in the embryonic gonad, accelerated in postnatal testes, and 
persisted at significant levels in spermatozoa (Figure 1.16C). Furthermore, this class 
of genes was significantly enriched for developmental regulators that direct the 
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differentiation of both germ and somatic cells, including Sox2, Cdx2, and Gata6, 
among others. (Figure 1.16D, E). The K4me3 and K27me3 patterns on these 
developmental genes remained stable in both embryonic and postnatal germ cells, but 
some of them resolved to K4me3 or K27me3 monovalent chromatin in somatic cells 
(MEFs) (Figure 1.16E). Importantly, these germline-poised developmental genes 
shared similar K4me3 and K27me3 modification patterns with cultured SSCs, 
providing support for the concept that germ cell identity in SSC cell lines is 
maintained long-term in vitro. 
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Figure 1.16. SSCs maintain consistent promoter bivalency with germ cells in vivo. 
(A) Dendrogram based on PRIMs of all promoters with K4me3+K27me3 bivalent 
histone modification in SSCs. Cells with the same or similar function were labled 
with the same color. Green, pluripotent ESCs (Mikkelsen et al., 2007; Wamstad et 
al., 2012) and MASCs. Orange, PGCs collected at different developmental stages 
(Lien et al., 2011; Ng et al., 2013). Red, cultured SSCs (Hammoud et al., 2014). 
Dark red, pre- or post-meiotic germ cells isolated from adult testes (Lien et al., 
2011; Erkek et al., 2013). Black, somatic cells, including MEFs  (Mikkelsen et al., 
2007), quiescent (q-)/activated (a-) hair follicle stem cells (HFSCs), hair follicle 
transient-amplifying matrix cells (HFTACs) (Lien et al., 2011), Hematopoietic 
stem cells (HSCs), and Macrophages. ChIP-seq data source or strain information is 
listed in brackets. Mouse strain includes B6, OG, VG, H3.3HA. 
(B) k-means clustering of genes by similarity of K4me3 and K27me3 profiles at SSC 
bivalent gene promoters. Green, K4me3. Red, K27me3. Cluster I, 358 genes. 
Cluster II, 276 genes. Cluster III, 1713 genes. PS, pachytene spermatocyte. RS, 
round spermatid. 
(C) Histone modification profiling at promoters of all cluster I genes as grouped in 
Figure 1.16B. Y-axis, average read count within promoter region. Green box, 
K4me3 modification. Red box, K27me3 modification. Dashed green line, average 
read count of K4me3 modification at all promoters in each cell type. Dashed red 
line, average read count of K27me3 modification at all promoters in each cell type. 
(D) GO enrichment using iPAGE. Genes were grouped by promoter K4me3 and 
K27me3 profiles as in Figure 1.16B. 
(E) Histone modification at selected genes. Green, K4me3 modification. Red, K27me3 
modification. K4me3 track range, 0 – 1. K27me3 track range, 0 – 0.5. 
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9. Histone variant H3.3 is preserved at core pluripotency genes in 
SSCs. 
In addition to histone modificaitons, several histone variants are also suggested to play 
important roles in transcription regulation and cell development. Recently, genome-
wide study of H3.3 localization in mammalian post-meiotic germ cells has shown that 
H3.3 is preserved at many developmental loci in haploid round spermatids and mature 
spermatozoa (Erkek et al., 2013). This finding raises an intriguing hypothesis that 
H3.3 could carry and transfer epigenetic information between generations, and its 
developmental gene-specific localizaiton in paternal genome potentially indexes the 
activation of these genes upon fertilizaiton.  
Activation of key pluripotency genes is a critical step in cell reprogramming. To 
elucidate the potential role of H3.3 in SSC reprogramming, we investigated genome-
wide H3.3 enrichment in cultured SSCs by ChIP-seq. SSCs were derived from adult 
mouse that carries a HA epitope tag at the C-terminal of endogenous H3f3b gene 
(H3.3-HA). After in vitro expansion under standard SSC culture condition, cells were 
collected and subjected to ChIP with antibody against HA epitope and then submitted 
for sequencing. Besides, H3.3 ChIP-seq results were also collected from ESCs and 
MEFs from the same mouse strain. For comparisons, we reprocessed data from 
published datasets for haploid round spermatids and mature spermatozoa (Erkek et al., 
2013). 
To evaluate the sequence signal of H3.3 at every gnomic locus in each cell type, 
the whole mouse genome was segmented into non-overlapping 1kb windows, and 
H3.3 sequence read count per window was calculated by SNPseeqer developed in Dr. 
Elemento’s lab. Interestingly, correlation clustering with genome-wide H3.3 
enrichment indicates that H3.3 distribution in SSCs is relatively similar to ESCs than 
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to MEFs. Conversely, post-meiotic germ cells including round spermatids and 
spermatozoa are more distant from the other deploid cells, presumabably due to the 
global histone-to-protamine exchange in round spermatids (Figure 1.17A). 
By examining H3.3 localization in SSCs, we noticed that most genes that are 
expressed in ESCs but silent in SSCs are not enriched with H3.3. However, H3.3 is 
significantly enriched at both gene bodies and regulatory regions (promoters, 
enhancers) of the three well-known core pluripotency genes Pou5f1/Oct4, Nanog, and 
Sox2 in SSCs (Figure 1.17B). Although RNA-seq showed that these three ESC-
specific transcription factors are barely expressed in SSCs, the H3.3 distribution 
patterns are surprisingly similar between ESCs and SSCs. Conversely, H3.3 does not 
occupy the promoters and gene bodies of Sox2 and Nanog in differentiated MEFs, but 
remains modestly detectable at these pluripotency genes in haploid round spermatids 
and mature spermatozoa (Figure 1.17B). 
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Figure 1.17. H3.3 is preserved at core pluripotency genes in SSCs. 
(A) Dendrogram based on genome-wide H3.3 enrichment profiles.  
(B) H3.3 enrichment at selected genes. Blue, H3.3. Black, RNA-seq result. Orange, 
ESC-specific enhancer region. Same data range is applied to all cell types for H3.3 
tracks (0 – 0.3) and RNA-seq tracks (0 – 2.0), except for H3.3 tracks for round 
spermatids and spermatozoa (0 – 0.15). 
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IV. Discussion 
Here, we evaluate the genomic localization of several transcription-associated histone 
modifications in mouse SSCs and their reprogrammed counterparts (MASCs). In 
depth analyses of the SSC epigenome at transcription regulatory loci, coupling with 
corresponding gene expression profiling, reveal that while the somatic gene promoters 
maintain stable K4me3+K27me3 bivalent histone modification, promoters and 
enhancers of ESC and germ cell signature genes undergo significant epigenetic 
changes after SSC reprogramming into a multipotent state. This gene-specific 
epigenetic conversion not only reflects the transcriptome difference between SSCs and 
MASCs, but also provides several insights about the unique biological characteristics 
in SSCs. And the SSC epigenome could play a critical role in both cell reprogramming 
in vitro and differentiation in vivo (Figure 1.18).  
 
1. SSC conversion is an unique reprogramming event. 
Somatic cells (i.e. MEFs) reprogramming to induced pluripotent stem cells (iPS) can 
be initiated by overexpression of several key pluripotency-associated transcription 
factors. A stepwise process has been proposed to take place during the switch from 
lineage-defined cells to pluripotent ESC-like cells (Samavarchi-Tehrani et al., 2010; 
Buganim et al., 2012). This reprogramming process could include the transcription 
events transfer from early stochasticity to more deterministic and hierarchic later 
phase in reprogramming cells, as it has been suggested by the marker gene expression 
changes at different reprogramming stages (Buganim et al., 2012). According to this 
model, overexpression of key pluripotency-associated transcription factors 
stochastically induces gene expression and initiates reprogramming, and the random 
activation of endogenous pluripotency genes progressively establishes ESC-like 
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hierarchic transcriptional regulation, which eventually stablizes the pluripotent stem 
cell identity at the end of this cell fate transition. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18. Model of epigenome changes during SSC conversion to MASC. 
SSC conversion involves change of epigenome at both cell-type-specific promoters 
and enhancers. Together with gene reactivation and silencing in reprogrammed 
MASCs, K4me3 modification (K4) is enriched at the promoters of pluripotency-
associated genes but depleted from promoters of germline-specific genes. Conversely, 
K27me3 modification (K27) is erased from several pluripotency-associated gene 
promoters. However, K27me3 modification ‘poises’ both germline- and somatic-
specific gene promoters together with K4me3 modification. Many of these (K4+K27) 
bivalent modified promoters are targets of PRC2 (Suz12) in pluripotent ESCs. At 
enhancer regions, MASCs are erased of most germ cell signature enhancer activity (S) 
marked by H3K27ac modification, but partially activate ESC-specific enhancers (E). 
In summary, MASCs acquire ESC-like epigenome at promoters and a subset of ESC-
specific enhancers. Dark blue box, completely activated enhancer. Light blue box, 
incompletely activated enhancer. White box, silent enhancer. 
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Conversely, considering the nature of SSC conversion, which happens 
spontaneously in standard SSC culture condition without any exogenous gene 
induction, the multipotent MASCs could be derived from a reprogramming process 
distinct from iPS formation. We proposed that intrinsic genetic and epigenetic features 
rather than enforced expression of ectopic transcription factor(s) are responsible for 
SSC conversion. In our model, SSCs are poised to tri-lineage differentiation by ESC-
like genetic or epigenetic factors in their own genome. This intrinsic developmental 
flexibility provides SSCs the chance of retrieving multipotent developmental 
characteristics during long-term proliferation in vitro. However, It is still unknown 
what induces SSC reprogramming process. Either a slight change of culture 
environment or progressive accumulation of unknown reprogramming initiation 
factors could be responsible for the cell fate transition from defined germline lineage 
to all three somatic germ layers. 
 
2. Transcriptome change involved in SSC conversion. 
Transcriptome analysis reveals that MASCs not only activate somatic cell- and ESC-
expressed genes but also repress germ cell differentiation regulators. During early 
embryogenesis, many of these activated genes are expressed in the inner cell mass 
(ICM), the embryonic origin of ESCs, and are considered marks of stem cell 
pluripotency. This transcriptiome change implies that SSCs reach a ESC-like 
developmental state through recovery of a broad range of embryonic developmental 
programs and erasure of adult germ cell characteristics. Both processes could be 
critical to the achievement of somatic lineage differentiation potential in MASCs. Our 
model suggests that intrinsic biological features are responsible for SSC conversion. 
Therefore, the transition from germline to embryonic transcriptome is presumably well 
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orchestrated under the SSC genome and/or epigenome, rather than stochastically 
induced as being suggested during somatic cell reprogramming to iPS.  
My intensive study on epigenome shows that somatic gene promoters are poised 
for transcription in SSCs by both K4me3 and K27me3 histone modifications. Despite 
of significant expression changes after SSC conversion, these genes maintain bivalent 
promoter modifications in MASCs (MASCStable I and MASCStable II). This poised 
promoter chromatin state potentially provides flexible transcriptional switch on 
somatic genes, and activation of these embryonic developmental programs could be 
one of the early events that initiates SSC conversion.  
However, my study also shows that the promoters and enhancers of these 
epigenetically poised genes are potentially regulated by both PRC2(Suz12)-mediated 
K27me3 and by transcription factors, including the core pluripotency,regulators 
Pou5f1/Oct4, Sox2, and Nanog. Many of these transcription factors undergo 
significant expression increase (Class I) and promoter histone modification changes 
during SSC conversion. These results indicate that a few ESC-specific transcription 
factors could be on top of somatic genes in the reprogramming hierarchy. That is, 
epigenetic switches at the promoters of key transcription factors could be essential to 
their transcription activation and the initiation of SSC conversion, while somatic genes 
represent downstream targets of this hierarchical network.  
On the other hand, silence of adult germ cell-specific genes could also initiate SSC 
conversion. Unlike somatic genes, promoters of these germline-expressed genes (Class 
II) mainly accumulate with K27me3 or lose K4me3 in MASCs, indicating that 
epigenetic regulation potentially provide direct impact on the silence of these germ 
cell-specific genes after SSC conversion. Given that germline-specific gene products 
potentially dominate over and repress somatic genes in SSCs, silence of these genes 
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could release the repression on stably poised genes (MASCStable I and MASCStable II) in 
SSCs and initiate their expression in MASCs.  
Because SSC conversion is a rare and long-term event without established 
induction protocol, it is difficult to identify the initiation factors of this process with 
current techniques. We were unable to complete time-series study on reprogramming 
SSCs, especially at the initiation stage of the reprogramming process, making it hard 
to study the first step of SSC transcriptome transition. Although histone modification 
change potentially provides significant impact on expression increase of key 
pluripotency genes and decrease of spermatogenesis genes, it is hard to exclude the 
possibility that epigenetically poised somatic genes initiate SSC conversion through 
direct response to the reprogramming-associated signaling. Identification of the 
regulators that promote the transcriptome transition will be essential to understand the 
mechanism of SSC conversion and to improve the reprogramming efficiency. 
We also noticed that several mesenchymal and epithelial genes are specifically 
expressed in MASCs (Class V). Their promoters are poised with bivalent 
modifications in both SSCs and MASCs. It raises the possibility that the completion of 
SSC conversion involves a mesenchymal-epithelial transition (MET), which has been 
proposed to be a critical step in initiating iPS formation (Samavarchi-Tehrani et al., 
2010). However, it is unknown whether MET gene expression is a stable feature of 
MASCs, or it is just a consequence of MASCs differentiation to mesenchymal and 
epithelial lineages. Further examination of MASCs transcriptome with improved 
culture condition (i.e., 2i medium) will be necessary to address this quesiton. 
Taking together, time-series study on the entire SSC conversion process, together 
with in-depth analyses of the transcriptome and corresponding epigenome, will be 
necessary to understand the mechanism of this unique cell reprogramming event. 
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3. Stable pluripotency-associated epigenetic signatures underlying 
germline development. 
Study of epigenome shows that SSCs preserve ESC-like epigenetic features at both 
promoters and enhancers. In contrast to the differentiated cells that have been 
analyzed, promoters of embryonic differentiation-associated genes maintain 
K4me3+K27me3 bivalent modifications in both SSCs and ESCs. Moreover, several 
ESC signature genes are also poised with bivalent modifications at promoters and 
histone variant H3.3 in gene body in SSCs. Besides, motif study of active enhancers 
shared among SSCs, MASCs, and ESCs suggests that core pluripotency circuitry is 
partially active in SSCs. This unique epigenetic milieu could facilitate the 
transcriptional switch in the presence of an internal or external stimulus and endow 
SSCs with unusual developmental flexibility with respect to all lineages in addition to 
the germline. 
Recently, it has been reported that a set of developmental genes are poised with 
K4me3+K27me3 bivalent modification in mamalian germline, from PGCs, the 
embryonic progenitors of SSCs, to mature spermatozoa (Lesch et al., 2013; Ng et al., 
2013; Sachs et al., 2013). Our findings in SSCs further confirm the developmental 
plasticity in the adult germ cells. Besides, our data shows that long-term in vitro 
cultured SSCs preserve chromatin modifications at selected promoters as do 
progenitor cells in vivo. The amazing chromatin consistency on developmental gene 
promoters suggests that germline epigenome could ensure stable transfer of epigenetic 
‘memory’ to the next generation, despite of global epigenomic changes in embryonic 
gonad and during meiosis. Further study on these genes with germline-stable and -
specific epigenetic marks will shed light on our understanding of the initiation of 
embryogenesis.  
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4. How to improve SSC conversion? 
a. Improving SSC epigenome by small molecules in culture  
After SSC conversion, MASCs are depleted of germ cell-specific epigenetic signatures 
at most cis-regulatory regions. Instead, MASCs acquire nearly completely ESC-like 
promoter chromatin modifications but partially activate pluripotent ESC-specific 
enhancers. Because MASCs have the capability of differentiating to all germ layers 
during teratoma formation, promoter histone modifications, together with enhancers 
shared between MASCs and ESCs, could be sufficient to support ESC-like tri-lineage 
differentiation. Those enhancers that remain silent in MASCs are presumably not 
essential to the core pluripotency circuitry, but could be induced during long-term 
culture or with improved growth condition.  
However, SSC reprogramming process takes over months and is about 100-fold 
less efficient than generating iPS from MEFs. Besides, MASCs are known to be 
inefficient in both chimera contribution and germline transmission, and completely 
lack tetraploid complementation ability (Kanatsu-Shinohara et al., 2004; Seandel et al., 
2007). As a result, it will still be important to investigate whether the establishment of 
complete embryonic-like enhancer activity can improve SSC conversion and MASC 
developmental potency to multiple lineages. One possible solution is to improve the 
K27ac-defined epigenome in culture by histone deacetylases (HDACs) inhibitors (i.e., 
VPA) (Huangfu et al., 2008). Development of novel, transcription factor-free, 
enforced reprogramming strategies will greatly benefit stem cell application in the 
clinic, and will also improve our understanding on the origin of totipotency during 
development. 
 
b. Potential role of K4 and K27 methyltransferase/demethylase in SSC conversion 
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After SSC conversion, most pluripotency gene promoters switch to active chromatin 
states with erasure of K27me3 modifications (MASCActive) or acquisition of the 
K4me3 modifications (MASCM). Conversely, promoters of germ cell differentiation 
genes are mainly repressed with K27me3 modifications (MASCRepress) or silenced with 
loss of K4me3 (MASCNM). Besides, many incompletely reprogrammed promoters 
(Class III, IV) achieve ESC-like chromatin states, indicates that epigenetic conversion 
on these genes presumably takes place prior to actual transcriptional changes. It 
suggests that H3K4- and H3K27- specific methytransferases and demethylases may 
play active roles in SSC conversion, for example, by facilitating chromatin state 
changes at selected promoters. Further study of enzymes that mediate H3K4 and 
H3K27 covalent modification, particularly those specifically expressed in SSCs, could 
be necessary to improve reprogramming efficiency. 
 
c. Potential role of H3.3 in SSC conversion 
Genome-wide study of H3.3 enrichment in cultured SSCs reveals that H3.3 is highly 
preserved at the three core pluripotency-associated transcription factors, Pou5f1/Oct4, 
Nanog, and Sox2. This unique deposition can not be simiply explained by 
transcription activity, as RNA-seq shows that these three genes are barely transcribed 
in SSCs. Therefore, it raises an intriguing hypothesis that H3.3, as K4me3+K27me3 
bivalent modification, could poise these genes for activation in SSCs. This leads to my 
in-depth study of H3.3 activity in cell reprogramming (Chapter two). To dissect the 
initiation stage of general cell reprogramming process, the transcription factor-induced 
iPS formation from MEFs was used as a model system. 
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CHAPTER TWO 
 
HISTONE VARIANT H3.3 IS ENGAGED IN 
PLURIPOTENCY-ASSOCIATED GENE 
ACTIVATION DURING MOUSE EMBRYONIC 
FIBROBLAST REPROGRAMMING 
 
 
I. Summary 
To investigate the role of H3.3 during mammalian cell reprogramming, we evaluate 
the dynamic changes of transcriptome and corresponding H3.3-defined epigenome 
during MEFs reprogramming to transcription factor-induced pluripotent stem cells 
(iPS). Time-series analyses suggest that global H3.3 replacement initiates at the early 
stage of MEFs reprogramming (first ten days). Notably, a H3.3-signified ESC-like 
chromatin landscape is established prior to corresponding pluripotent gene activation. 
Furthermore, H3.3 replacement not only associates with K27me3 reduction at the 
promoters and enhancers of ESC signature genes, but also with re-establishment of 
K4me3+K27me3 bivalent modifications at embryonic differentiation gene promoters. 
Our study suggests that, upon reprogramming initiation, H3.3 is a novel epigenetic 
regulator that is involved in pluripotency gene activation through remodeling 
differentiated cell chromatin. This result, together with the notion that H3.3 is pre-
deposited at key pluripotent genes in unipotent SSCs, shed light on our study of 
epigenetic regulation during cell reprogramming. 
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II. Introduction 
Series of programming events orchestrate mammalian development from a fertilized 
zygote to an adult individual. While differentiated cells can also be reprogrammed to 
pluripotency by nuclear transfer, cell fusion, over-expression of a set of defined 
transcription factors, or spontaneous reversion (SSC culture only) (Takahashi and 
Yamanaka, 2006; Seandel et al., 2007; Wen et al., 2014b).  
Histone H3 variant H3.3 has been implicated in chromatin remodeling and 
epigenetic regulation of gene expression during various mammalian cell development 
processes (Banaszynski et al., 2010). In the early mouse zygote, maternal H3.3 plays 
an important role in male pronucleus formation before the transcription activation in 
parental pronuclei (van der Heijden et al., 2005; Torres-Padilla et al., 2006). H3.3 
deposition into the paternal genome is suggested to be critical for the establishment of 
pericentric heterochromatin, which ensures proper chromosome segregation during the 
first mitosis (Santenard et al., 2010). Accumulating evidences implicate that H3.3 also 
functions in germline development during adulthood (Banaszynski et al., 2010). 
Significant level of H3.3 has been identified in differentiating germ cells (Figure 10). 
Recent genome-wide studies further suggest that H3.3 is the dominant H3 histone in 
post-meiotic germ cells, including round spermatids and mature spermatozoa. The 
H3.3-nucleosomes, together with K4me3 and K27me3 modifications, enrich at a broad 
range of developmental genes in mouse spermatozoa (Erkek et al., 2013). These 
findings endow H3.3 and corresponding modifications prime candidacies for 
epigenetic inheritance across generations.  
Besides of normal cell development, H3.3 is proposed to be a critical epigenetic 
activator that initiates cell reprogramming to a pluripotency state. Study in somatic 
cell nuclear transfer (SCNT) embryos suggests that H3.3, but not H3.1/H3.2, is a 
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maternal “reprogramming factor” that is essential for chromatin reorganization in the 
donor nucleus, resulting in pluripotency gene reactivation that reprograms a 
differentiated cell to a ESC-like cell (Jullien et al., 2012; Wen et al., 2014a). In mouse 
ESCs, H3.3 is suggested to be required for proper establishment of K4me3+K27me3 
bivalent chromatin modification, an epigenetic character that is specific to pluripotent 
stem cells. Several lineage-specific genes are misregulated with reduced levels of 
K27me3 in H3.3-depleted ESCs, resulting in alteration of the differentiation potential 
of ESCs (Banaszynski et al., 2013). It consists with the finding that, although 
knocking out H3.3 specific chaperon HIRA in mouse ESCs gives no observable effect, 
HIRA-/- mutant causes embryonic lethality at the gastrula stage (Roberts et al., 2002). 
We therefore explored the potential role of H3.3 in facilitating cell reprogramming 
to pluripotency. The well studied transcription factor-induced pluripotent stem cells 
(iPS) formation method was applied to model general cell reprogramming process. To 
study the activation process of pluripotency genes, time-series studies on both 
transcriptome and epigenome of the reprogrammed MEFs (rMEFs) were performed 
during the first ten days of iPS formation. Our results suggest that global H3.3 
replacement initiates at the early stage of MEFs reprogramming, particularly at the 
promoters and enhancers of ESC signature genes. This H3.3 replacement establishes a 
pluripotent ESC-like chromatin landscape prior to corresponding gene activation. 
Besides, promoter H3.3 replacement not only associates with K27me3 reduction at 
ESC signature genes, but also with re-establishment of bivalent modification at 
embryonic differentiation genes. 
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III. Result 
1. Global H3.3 replacement initiates right after the induction of 
MEFs reprogramming. 
To understand the potential role of H3.3 in mammalian cell reprogramming, we 
applied ChIP-seq to identify genomic loci with dynamic H3.3 deposition during 
transcription factor-induced pluripotent stem cells (iPS) formation (Table 2.1). To this 
end, mice carrying a single dox-inducible Oct4/Sox2/Klf4/Myc (OSKM) polycistronic 
4F2A cassette (tetO-4F2A) (Carey et al., 2010) were crossed with H3.3-HA mice 
(Wen et al., 2014c). MEFs were then isolated from E13.5 embryos of this tetO-4F2A x 
H3.3-HA strain and cultured with doxycycline to give rise to germline-transmission 
competent iPS (data not shown). To focus on early reprogramming events, 
reprogramming MEFs (rMEFs) were collected at 0, 3, 6 and 10 days after doxycycline 
induction, then applied to ChIP-seq on HA epitope tag of H3.3 and RNA-seq for gene 
expression profile (Table 2.2). ESCs and completely reprogrammed iPS (ESC-like 
cells over 20 days of induction) were used as pluripotent cell controls. The first ten 
days were considered as early stage of MEFs reprogramming, and time after ten days 
was considered as late stage of reprogramming (Figure 2.1). By comparing with ChIP-
seq result in MEFs without doxycycline induction (day 0), a H3.3 replacement locus 
was selected as any genomic region in rMEFs (day 3, 6, 10) or iPS with H3.3 ChIP-
seq average read count increasing over 0.15, a threshold selected basing on the 
distribution of H3.3 ChIP-seq read count change at all promoters (Figure 2.2A). (This 
system can detect that H3.3 replaces H3.1 or H3.2, but is not able to detect when H3.3 
replaces H3.3). 
Intriguingly, time-series result suggests that H3.3 replacement initiates as early as 
day 3 after doxycycline induction, the first time point we collected. We found over 
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one-fourth of promoters (-2kb ~ TSS) with H3.3 replacement in iPS, which is higher 
than other genetic loci (Figure 2.2B). It suggests that promoter is the most active 
region for H3.3 replacement during early reprogramming. We found significant H3.3 
replacement at 7.2% to 13.8% promoters within ten days of induction, and at 27.4% 
promoters in completely reprogrammed iPS (Figure 2.2B). Similar percentage of H3.3 
replacement was observed within gene body and distal region (over 2kb from 
transcript), but not at the end of transcipts (downstream) (Figure 2.2B). As a validation 
of sequencing result, we also examined H3.3 enrichment at promoters of several 
pluripotency genes by ChIP-qPCR, which showed that H3.3 deposition significantly 
increases from day 3 to day 6, while total H3 level remains unchanged or only slightly 
increased (Figure 2.2C). This result suggests that the increase of H3.3 deposition at 
these loci is a result of H3.3 replacement, not increase of nucleosomal density. 
 
 
Figure 2.1. Schematic of experimental system and time points of data collection 
and sequence analyses. (All the mouse work and cell collection were completed by 
Dr. Duancheng Wen)  
High-throughput Sequencing: 
Ø ChIP: H3.3-HA, K27me3 
Ø RNA 
0    3    6   10 …………> 20 (iPS) 
Collection Day:                       
      Early              Late 
  
H3.3-HA 
tetO-4F2A 
X E13.5 
MEFs 
(tetO-4F2A x H3.3-HA) 
 
Induce pluripotent stem 
cells (iPS) by doxycycline  
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Figure 2.2. H3.3 replacement initiates at promoter and other genomic regions 
upon the induction of MEFs reprogramming. 
(A) Probability distribution of H3.3 enrichment change at all promoters. X-axis, 
average H3.3 ChIP-seq read count difference between certain time point and 
MEFs (day 0). Y-axis, density of probability. Light blue, day 3. Blue, day 6. Dark 
blue, day 10. Dashed line, threshold of H3.3 increase (0.15, replacement) or 
decrease (-0.15).   
(B) Percentage of genomic regions with H3.3 replacement during MEFs 
reprogramming. H3.3 replacement loci were selected by comparing ChIP-seq 
signal between certain time point and MEFs (day 0). Dark blue, promoter (-2 kb ~ 
TSS). Light blue, distal region (over 2 kb from transcript). Green, gene body 
(including exon and intron). Grey, downstream (TES ~ 2 kb).  
(C) ChIP-qPCR on H3.3 (left) and general H3 (right) at selected promoters. (This 
experiment was completed and analyzed by Dr. Laura A. Banaszynski) 
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2. Promoter H3.3 replacement establishes a pluripotent ESC-like 
chromatin landscape prior to gene activation. 
To assess the relationship between H3.3 replacement and gene activation during cell 
reprogramming, we then focused on genes that are de novo activated in completely 
reprogrammed iPS (iPS activated genes). These genes were defined as being 
completely silenced or expressed at low level in MEFs (day 0) but increasing their 
expression over 2 folds (log2-based) in iPS (see Methods) (Figure 2.3A). Basing on 
these criteria, we selected 2,069 iPS activated genes from RNA-seq result for in-depth 
analyses (Table 2.3). As a control, we randomly selected 2,000 genes that remain 
silent or low expression in both MEFs and iPS (iPS stable genes) (see Methods) 
(Figure 2.3A, Table 2.4).  
Strikingly, H3.3 replacement was detected at the promoters of 43.1% (891) iPS 
activated genes within the first ten days of reprogramming (early replacement), and at 
27.3% (565) promoters after ten days but in iPS (late replacement) (Figure 2.3B, Table 
2.3). Both groups maintained high promoter H3.3 level in iPS (Figure 2.4A). Within 
the whole reprogramming period, H3.3 deposition did not significantly increase at the 
rest of 29.6% (613) iPS activated gene promoters (no replacement) (Figure 2.3B, 
Table 2.3). Within 2,000 iPS stable genes, however, only 22.5% (449) and 18.2% 
(364) promoters were found with early and late H3.3 replacement (Figure 2.3B, Table 
2.4). Conversely, nearly 60% iPS stable gene promoters did not have H3.3 
replacement but remained low level of H3.3 throughout MEFs reprogramming (Figure 
2.3B, 2.4B, Table 2.4). We also noticed that iPS activated genes had early promoter 
H3.3 replacement initiated immediately after doxycycline induction (day 3), and 
reached the iPS-like H3.3 deposition level at day 10 (Figure 2.4A).  
 
 103 
  
 
 
 
 
Figure 2.3. iPS activated genes are significantly enriched with H3.3 at promoter. 
(A)  Expression of 2069 iPS activated genes (black) and 2000 iPS stable genes (grey) 
in MEFs (day 0) and iPS. Y-axis, gene expression (log2-transformed). Grey 
dashed line, average of all gene expression at corresponding time point. 
(B) Percentage of promoters with H3.3 replacement within the first ten days of 
reprogramming (Early, dark blue), after ten days but in iPS (Late, blue), or without 
H3.3 replacement (No, light blue).  
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Figure 2.4. Promoter H3.3 replacement during MEFs reprogramming. iPS 
activated genes are significantly enriched with H3.3 at promoter. 
H3.3 enrichment at (A) iPS activated gene promoters and (B) iPS stable gene 
promoters. Dark blue, early H3.3 replacement. Light blue, late H3.3 replacement. 
Grey, no H3.3 replacement. Y-axis, average read density within promoter region (-2 
kb ~ TSS) with log2-transfer. Blue dashed line, average of H3.3 enrichment at all 
promoters at corresponding time point. 
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We then studied the relationship between promoter H3.3 replacement and 
transcription activation. To our surprise, within the 891 iPS activated genes with early 
H3.3 replacement at promoters, only less than one-third (249) genes increased their 
expression during the period of H3.3 replacement (Figure 2.5A, B). This result 
suggests, intriguingly, that the majority of genes undergoing promoter chromatin 
remodeling do not change their transcription together with H3.3 replacement. 
Importantly, these genes were expressed later in iPS (Figure 2.5A, B). Gene ontology 
(GO) analysis revealed that iPS activated genes with either early or late promoter H3.3 
replacement mainly regulate ESCs self-renewal and differentiation (Figure 2.5C, 
Table 2.5), including many key pluripotency genes such as Pou5f1/Oct4, Sox2 and 
Nanog (Figure 2.5B).  
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Figure 2.5. Promoter H3.3 replacement establishes a pluripotent chromatin 
landscape prior to gene activation. 
(A) Expression of 891 iPS activated genes with early H3.3 replacement at promoters. 
Genes are divided by expression patterns during the first ten days of 
reprogramming, including expression change (249 genes, pink box) and expression 
stable (642 genes, green box). Y-axis, gene expression (log2-transformed). Grey 
dashed line, average of all gene expression at corresponding time point. 
(B) Transcription and H3.3 enrichment profiling for selected iPS activated genes at 
different time points of MEFs reprogramming. Left, gene expression, red and 
green indicate relative higher and lower expression, respectively. Right, H3.3 
enrichment measured by average read count within promoter region, blue and 
white indicate relative higher and lower H3.3 enrichment, respectively. 
(C) Gene ontology (GO) enrichment using iPAGE for iPS activated genes (Active) and 
iPS stable genes (Stable). Genes were grouped by promoter H3.3 replacement type 
as in Figure 2.3B. Enrichment and depletion of certain GO functions (shown on 
the right) are measured by hypergeometric p-value (log10-transformed). The first 
column contains control gene genes that do not belong to any of the other 6 groups. 
Red, over representation. Blue, under representation. 
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3. Promoter H3.3 replacement associates with K27me3 reduction at 
ESC signature genes and re-establishment of bivalent modification at 
embryonic differentiation genes. 
It has been suggested that chromatin histone modification is key to transcriptional 
regulation and cell reprogramming. In particular, K27me3 modification at promoters 
associates with gene silencing, providing tight control over transcription during both 
iPS formation and ESC differentiation. Therefore, we examined whether H3.3 
replacement associated with gene activation with the adjustment of corresponding 
promoter K27me3 modification during MEFs reprogramming. rMEFs were collected 
in the time-series study as described above and applied to ChIP-seq on K27me3 
modification at each time point (Figure 2.1).  
Among 24,033 unique transcripts in our study, we identified 8,722 promoters with 
early H3.3 replacement (first ten days) during MEFs reprogramming, and nearly half 
of them (4,264) had marginally detectable K27me3 modification before doxycycline 
induction (day 0) (Figure 2.6A, Table 2.6). These low K27me3 promoters were mainly 
transcribed in both MEFs and iPS (Figure 2.6B) with housekeeping functions in 
metabolic process and cell cycle (Figure 2.6C, Table 2.7).  
The rest of 4,458 promoters with early H3.3 replacement were enriched with 
K27me3 modificaiton in MEFs (day 0) (Figure 2.6A, Table 2.6). Strickingly, 41.0% of 
them (1,829/4,458) lost K27me3 during reprogramming, significantly higher than 
those promoters without H3.3 replacement (23.2%, 1,904/8,192) (Fisher's exact test, 
p-value < 2.2e-16) (Figure 2.7A). Notably, 85.1% (Class I, 1,557/1,829) promoters 
progressively lost K27me3 during early reprogramming, with the modification 
changed together with H3.3 replacement as early as at day 3 (Figure 2.7B, C). These 
promoters mainly regulate stem cell development genes, including the key 
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pluripotency genes Pou5f1/Oct4 and Nanog, as well as many pluripotency-associated 
genes (Figure 2.8, 2.9). This result suggests that K27me3 depletion at pluripotency 
gene promoters concurrented with H3.3 replacement upon initiation of cell 
reprogramming. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Promoters with high K27me3 in MEFs and early H3.3 replacement 
during reprogramming are enriched for developmental functions. 
(A) K27me3 modification change at promoters with early H3.3 replacement. Y-axis, 
average read density within promoter region (log2-transformed). Red dashed line, 
average of K27me3 enrichment at all promoters at corresponding time point. 
(B) Expression of genes with early H3.3 replacement at promoters. Genes are grouped 
by K27me3 level as in Figure 2.6A. Y-axis, gene expression (log2-transformed). 
Grey dashed line, average of all gene expression at corresponding time point. 
(C) Gene ontology (GO) enrichment in genes with low promoter K27me3 in MEFs 
(4264 genes, L) and genes with high promoter K27me3 in MEFs (4458 genes, H).  
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Figure 2.7. Promoter H3.3 replacement associates with the reduction of K27me3 
modification. 
(A) Percentage of promoters with K27me3 decrease (dark red), increase (red), or stable 
(pink) during early MEFs reprogramming (the first ten days). Promoters with H3.3 
replacement, 4458 genes. Promoters without H3.3 replacement, 8192 genes. 
(B) Promoters with high K27me3 modification in MEFs (day 0) and H3.3 replacement 
in rMEFs are classified by change of K27me3 modification during reprogramming.  
(C) K27me3 (top) and H3.3 (bottom) enrichment profiles near the promoters. TSS, 
transcription start site. Gene grouped as in Figure 2.7B.  
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Figure 2.8. Promoters with H3.3 replacement and K27me3 reduction are 
enriched with ESCs pluripotency- and differentiation-regulation functions. 
(A) Gene ontology (GO) enrichment for genes grouped as in Figure 2.7B. 
(B) Transcription, H3.3 enrichment, and K27me3 modification profilings for selected 
promoters during the 10-day period of reprogramming, iPS, and ESCs (E). Left, 
gene expression, red and green indicate relative higher and lower expression, 
respectively. Middle, H3.3 enrichment measured by average read count within 
promoter region, blue and white indicate relative higher and lower H3.3 
enrichment, respectively. Right, K27me3 modification measured by average read 
count within promoter region, red and white indicate relative higher and lower 
modification, respectively. 
(C) Venn diagram among genes with K27me3 increased at promoters during 10-days 
of induction (Class II, III) and ESC bivalent genes. 
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Figure 2.9. H3.3 and K27me3 enrichment at selected promoters. (a) Pou5f1; (b) 
Nanog; (c) Cdh9; (d) Atp13a3. Blue tracks, H3.3. Red tracks, K27me3. Red region, 
promoter selected for analysis (-2 kb ~ TSS). Grey region, enhancer. Data range 
for all tracks, 0 – 0.4. 
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Intriguingly, we also found many promoters with significant K27me3 upregulation 
at day 6 and day 10, some lost K27me3 at day 3 (Class II, 272 promoters), but some 
did not (Class III, 890 promoters) (Figure 2.7B, C, Table 2.6). As Class I promoters, 
both Class II and III promoters had H3.3 replacement as early as at day 3 and 
maintained it over the course of reprogramming (Figure 2.7C). However, these 
promoters mainly regulate embryonic development genes particularly function in 
mesodermal and epithelial lineages (e.g., Cdh1, Gdf7, Gata6) (Figure 2.8B), making 
them functionally distinct from Class I promoters or those with early H3.3 
replacement but stable K27me3 modification (Class IV, 1,739 promoters) (Figure 
2.8A, Table 2.6, 2.8). Moreover, over 40% (488/1,162) of promoters that acquired 
K27me3 modification after H3.3 replacement (Class II+III) were marked by both 
K27me3 and K4me3 modifications in ESCs, which were classified as bivalent 
promoters and considered specific epigenetic signatures in pluripotent stem cells 
(Figure 2.8C). 
 
4. H3.3 replacement at enhancers reveals transcriptional regulatory 
hierarchy during early stage of MEFs reprogramming. 
Genome-wide studies have shown that in addition to promoters, H3.3 is deposited at 
enhaners along with recruitment of cell-type specific transcription factors (Goldberg et 
al., 2010). Within the early stage of MEFs reprogramming (first ten days), we found 
H3.3 enrichment changed at intergenic regions distal from known transcripts, 
suggesting the H3.3 replacement at enhancers (Figure 2.2B). To identify MEFs 
reprogramming associated enhancers, we collected K27ac enriched intergenic loci in 
both MEFs and ESCs in published ChIP-seq data sets (Creyghton et al., 2010), and 
assigned loci with cell type specific K27ac enrichment MEF- or ESC-specific 
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enhancers (Figure 2.10A, Table 2.9). As expected, H3.3 progressively increased at 
ESC-specific enhancers but decreased at MEF-specific enhancers during iPS 
formation, and this change was detected as early as at day 3 after induction of 
reprogramming (Figure 2.10B). Besides, we also observed nearly two-thirds of ESC-
specific enhancers undergoing both H3.3 replacement and K27me3 decrease during 
early reprogramming, significantly higher than those enhancers without H3.3 
replacement (Fisher's exact test, p-value < 2.2e-16) (Figure 2.10C). 
To unveil the molecular mechanisms involved in MEFs reprogramming associated 
H3.3 replacement, we applied motif search with HOMER on ESC-specific enhancers 
with de novo H3.3 replacement at each time point of early reprogramming and in 
completely reprogrammed iPS (Figure 2.11, Table 2.10). Motifs preferentially 
enriched at these enhancers suggest that the exogenous expression of Oct4, Sox2, and 
Klf4 potentially activated ESC-specific enhancers right after doxycycline induction 
(day 3). However, c-Myc potentially associated with H3.3 replacement and enhancer 
activation slightly later, as the enrichment of c-Myc motif was only identified after 
day 6 of induction and in iPS (Figure 2.11, left). We also found many stem cell 
differentiation regulators potentially activated ESC-specific enhancers in 
reprogrammed iPS (e.g., Yy1, Foxp1, etc.), suggesting their roles in establishing 
developmental potency to multiple lineages. Conversely, MEF-specific enhancers 
depleting of H3.3 were enriched with no pluripotency associated transcription factors 
but mesodermal regulators (Figure 2.11, right).  
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Figure 2.10. ESC-specific enhancers are significantly enriched with H3.3 and 
reduced for K27me3 during MEFs reprogramming. 
(A) K27ac modification at cell type specific enhancers. Y-axis, average read intensity 
(log2) within selected enhancers. Yellow, MEF-specific enhancer. Orange, ESC-
specific enhancer. 
(B) H3.3 enrichment at cell type specific enhancers. White, MEF-specific enhancer. 
Grey, ESC-specific enhancer. Blue dashed line, average of H3.3 enrichment at all 
enhancers at corresponding time point. 
(C) Percentage of ESC specific enhancers with K27me3 decrease (Decrease), increase 
(Increase), or not change (Stable) within the initial 10 days of reprogramming. 
Black, ESC enhancer with H3.3 replacement (4935 enhancers). Grey, ESC 
enhancer without H3.3 replacement (5855 enhancers). 
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Figure 2.11. Enrichment of transcription factor binding motifs at ESC-specific 
enhancer (left) and MEF-specific enhancer (right) with H3.3 replacement at 
different time point. Each row represents a motif, and the corresponding transcription 
factors are labeled on the side. Red, transcription factors applied for iPS induction. 
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IV. Discussion 
There are several interesting points emerging from our study. 
1. H3.3 as an epigenetic regulator that is engaged in cell reprogramming. 
Time-series epigenomic study during iPS formation reveals that H3.3 replacement 
occurs at many pluripotency gene promoters and ESC-specific enhancers immediately 
after the initiation of MEFs reprogramming. Gene expression profiling at the same 
time point further suggests that H3.3 replacement takes place prior to corresponding 
gene activation. These results indicate that rather than simply marking regions of 
active transcription, de novo H3.3 deposition at the transcription regulatory regions of 
repressed genes may facilitate gene acitivation through the establishment of a 
pluripotent ESC-like chromatin landscape. 
 
2. H3.3 replacement associates with reduction of K27me3 modification at 
transcription regulatory loci and induction of pluripotency gene expression. 
Our epigenomic study during early and late stages of MEFs reprogramming reveals a 
close association between H3.3 replacement and K27me3 reduction at both promoters 
and enhancers. It will be important to evaluate whether H3.3 turnover at these 
transcription regulatory loci directly induces the decrease of H27me3 modification. 
Therefore, we hypothesize that through the replacement of chromatin H3.3 with newly 
synthesized H3.3, K27me3 modification could be removed from chromatin, which 
turns the H3.3 replacement locus from transcription repressive to permissive status 
(Figure 2.12). This K27me3 demethylase-independent model suggests a mechanism to 
remove repressive histone modifications at transcription regulatory loci for 
pluripotency gene reactivation.  
 118 
However, we could not exclude the possibility that demethylases function at the 
H3.3 replacement loci to erase K27me3 modification. It is therefore necessary to 
evaluate H3.3 replacement-associated K27me3 modification change with the 
inhibition of K27 demethylases, for example, inhibiting JMJD3 and UTX with GSK-
J4 (Figure 2.12) (Kruidenier et al., 2012). We propose that after efficient inhibition on 
K27 demethylases, K27me3 modification at transcription regulatory loci can still 
decrease to certain level with H3.3 replacement. Besides, we would confirm H3.3 
replacement effect on K27me3 modification change with Hira knockout (Hira-/-) 
MEFs, which lack H3.3 deposition at transcription regulatory loci (Figure 2.12). We 
propose that Hira-/- MEFs with K27 demethylases inhibitor treatment can not be 
effectly reprogrammed, as the pluripotency genes remain repressed with stable 
K27me3 modification. This defect can be rescued by over expressing H3.3 but not 
H3.1 or H3.2.    
 
 
 
 
 
 
 
Figure 2.12. Model of H3.3 replacement associated K27me3 modification change 
and gene activation. The promoter of a silenced gene has repressive modifications on 
histone H3 (i.e. K27me3, red flag). Newly produced H3.3 (unmodified H3.3) replaces 
original chromatin histone H3 at this promoter. This replacement removes original 
repressive modifications and turns the promoter chromatin into a permissive state, 
which can be transcriptionally activated (i.e. K4me3, green ball) or poised (i.e. 
K4me3+K27me3) with different histone modifications in reprogrammed cells.  
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3. H3.3 replacement associates with the establishment of ESC-like chromatin 
landscape, including bivalent modifications at developmental gene promoters. 
Beside of H3.3 replacement associated K27me3 reduction at ESC signature genes, we 
also found that K27me3 modification was re-established after H3.3 replacement at 
many developmental gene promoters. Many of these promoters carry 
K4me3+K27me3 bivalent modification in ESCs and are responsible for ESC 
differentiation to a broad range of cell types. This result implies that H3.3 replacement 
associates with proper establishment of bivalency in reprogrammed iPS. This 
hypothesis is supported by the recent study in H3.3-depleted mouse ESCs, which have 
K27me3 level reduced at several bivalent gene promoters upon removing of H3.3 
protein (Banaszynski et al., 2013). It has been suggested that H3.3 replacement 
facilitates a dynamic chromatin environment that allows for PRC2 binding and 
methylation at K27. Therefore, H3.3 replacement during the early stage of MEFs 
reprogramming potentially directs the establishment of bivalency at developmental 
gene promoters. It will be interesting to check whether H3.3-depleted MEFs can still 
go through reprogramming process to generate pluripotent iPS, and whether promoter 
bivalency can be properly established in reprogrammed cells. 
 
In summary, identification of ESC-like H3.3 enrichment in unipotent SSCs 
(Chapter one) raises an intriguing question that, besides of K4me3+K27me3 bivalent 
histone modification, H3.3 could be another epigenetic regulator that pre-deposit 
pluripotent developmental potential in unipotent SSCs. Our time-series study on 
global H3.3 replacement during iPS formation further suggests that H3.3 is a novel 
pluripotency activator that is involved at the initiation of cell reprogramming. In the 
future, it will be interesting to investigate whether SSC reversion can be improved 
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through overexpression of H3.3, as transcription factors do for iPS formation. 
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